Utah State University

DigitalCommons@USU
All Graduate Theses and Dissertations

Graduate Studies

5-2011

Factors Moderating the Association between Multiple Rating
Sources of Geriatric Depression: Self, Informant, and Physician
Daniel J. Hatch
Utah State University

Follow this and additional works at: https://digitalcommons.usu.edu/etd
Part of the Quantitative Psychology Commons

Recommended Citation
Hatch, Daniel J., "Factors Moderating the Association between Multiple Rating Sources of Geriatric
Depression: Self, Informant, and Physician" (2011). All Graduate Theses and Dissertations. 873.
https://digitalcommons.usu.edu/etd/873

This Thesis is brought to you for free and open access by
the Graduate Studies at DigitalCommons@USU. It has
been accepted for inclusion in All Graduate Theses and
Dissertations by an authorized administrator of
DigitalCommons@USU. For more information, please
contact digitalcommons@usu.edu.

FACTORS MODERATING THE ASSOCIATION BETWEEN MULTIPLE
RATING SOURCES OF GERIATRIC DEPRESSION:
SELF, INFORMANT, AND PHYSICIAN
by
Daniel J. Hatch
A thesis submitted in partial fulfillment
of the requirements for the degree
of
MASTER OF SCIENCE
in
Psychology

Approved:

Maria C. Norton, Ph.D.
Major Professor

JoAnn T. Tschanz, Ph.D.
Committee Member

M. Scott DeBerard, Ph.D.
Committee Member

Byron R. Burnham, Ed.D.
Dean of Graduate Studies
UTAH STATE UNIVERSITY
Logan, Utah
2011

ii

Copyright © Daniel J. Hatch 2011
All Rights Reserved

iii
ABSTRACT
Factors Moderating the Association between Multiple Rating Sources of Geriatric
Depression: Self, Informant, and Physician
by
Daniel J. Hatch, Master of Science
Utah State University, 2011
Major Professor: Dr. Maria C. Norton
Department: Psychology
Late-life depression is a major public health concern, associated with poor health
outcomes, including doubling of dementia risk. Psychiatric evaluation is impractical in
large epidemiological studies, which instead typically rely on self/informant reports,
which are subject to various biases (stigma, recall). Few studies have addressed level of
agreement between sources. This study examined associations between these sources and
assessed whether subject and informant variables moderated these associations. In a
population-based study of dementia in Cache County, Utah (2002-5), 1,480 subjects
completed an in-depth clinical assessment (CA). Major depression was assessed via the
self-report Patient Health Questionnaire-9 (PHQ-9) and informant-rated Neuropsychiatric
Inventory (NPI-CA). One hundred forty-eight subjects with cognitive impairment also
completed a psychiatrist’s examination, including the self-report Geriatric Depression
Scale (GDS), the informant-rated NPI (NPI-MD), and the physician’s clinical rating
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(PCR). Bivariate correlations were modest: NPI-CA versus PHQ-9 (r = .26), NPI-MD
versus GDS (r = .20), GDS versus PCR (r = .22), NPI-MD versus PCR (r = .45). Kappa
statistics and logistic regression models indicated that the NPI-CA predicted the PHQ-9
moderately (  =.08, p <.001; OR = 3.1, 95% CI: 1.5 to 6.1). Results also indicated that
the GDS did not significantly predict the PCR (κ = .10, p > .05; 95% CI: 0.7 to 11.2) nor
the NPI-MD (κ =.01, p > .05; 95% CI: 0.6 to 6.3), and that the NPI-MD predicted the
PCR moderately well (κ = .35, p < .001; OR= 11.1, 95% CI: 2.6 to 48.3). CA-NPI
predicted the PHQ-9 for cognitively normal subjects (κ =.13, p < .001; OR = 10.1, 95%
CI: 1.9 to 52.6) but not for subjects with mild impairment (κ =.01, p > .05; 95% CI: 0.4 to
4.3) nor dementia (κ = .14, p > .05; 95% CI: 0.9 to 7.8). No other variables moderated
these associations. Results suggest the importance of cognitive assessment when
measuring late-life depression via self-report.
(129 pages)
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CHAPTER I
INTRODUCTION
Depression is common among the elderly, with prevalence rates among this group
(defined in most studies as persons over age 65) ranging from 86% to 9.4% for major and
3.1% to 12.9% for minor depression (Djernes, 2006). This is particularly concerning
given finding that the proportion of elderly persons in the United States is increasing. For
instance, the U.S. Census Bureau projected that by the year 2030, one out of five persons
will be over the age of 65 (U.S. Census Bureau, 2008). Much research has been devoted
to late-life depression. Late-life depression is associated with increased risk for illnesses
such as heart disease (Williams et al., 2002), decreased immune functioning (McGuire,
Kiecolt-Glaser, & Glaser, 2002), and osteoporosis (Robbins et al., 2001), and is
associated with increased mortality after acute myocardial infarction (Carney et al.,
2003). Several studies, including a review by Jorm (2001), have found that depression
increases the risk for dementia (Dal Forno et al., 2005; Dotson, Resnick, & Zonderman,
2008; Fuhrer, Dufouil, & Dartigues, 2003; Hebert et al., 2000; Kessing & Andersen,
2004; Sachs-Ericsson, Joiner, Plant, & Blazer, 2005; Shim & Yang, 2006; Steffens et al.,
2004), while some have found that it does not increase this risk (Chen, Ganguli, Mulsant,
& DeKosky, 1999; Dufouil, Fuhrer, Dartigues, & Alperovitch, 1996; Henderson et al.,
1997; Vinkers, Gussekloo, Stek, Westendorp, & Van der Mast, 2004). Quality of life is
also often impaired in late-life depression sufferers. In a recent study by Doraiswamy,
Khan, Donahue, and Richard (2002), recurrent sufferers of late-life major depression, as
measured by the Hamilton Rating Scale for Depression (HAM-D; Hamilton, 1960)
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scored worse than a normative sample on five out of eight dimensions of the Medical
Outcomes Short Form-36 Health Survey (SF-36; Ware, 1993) including general health
perception, mental health, emotional functioning, social functioning, and vitality. Latelife depression also may contribute to withdrawal, apathy, lack of vigor (Adams, 2001),
fatigue, and some types of insomnia (Christensen et al., 1999), and increases the risk of
suicide (Conwell, Duberstein, & Caine, 2002; Minino, Arias, Kochanek, Murphy, &
Smith, 2002).
Before late-life depression can be studied or treated, it has to be accurately
diagnosed. However, several factors impede an accurate diagnosis of depression. Older
adults (and their family members) may consider depressed mood as a normal part of
aging, especially in the presence of stressful life events or chronic stressors (Allen,
Walker, Shergill, D’Ath, & Katona, 1998). Elderly users of some medications such as
antihypertensives may also experience depressed mood as a side effect of the medication
(Ried, Tueth, Handberg, Kupfer, & Pepine, 2005) and if such side effects were
anticipated, the depressed mood may likewise be considered normal “background”
experience and nothing noteworthy and thus, would go unreported.
The stigma associated with mental illness may well inhibit an accurate diagnosis,
especially among the elderly. A study by Allen and colleagues (1998) found that older
adults were more likely than younger adults to have negative beliefs about depression,
including the belief that depression mainly affects women and that it is unlikely to affect
elderly persons. It also found that elderly persons were more likely to report that they
would approach no one for help if they suffered from depression.
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Cultural beliefs among the elderly also inhibit accurate diagnosis. A study by
Switzer, Wittink, Karsch, and Barg (2006) found that when elderly participants were
asked questions about how one should treat depression, most participants’ (83%)
responses included themes involving personal responsibility, often using methaphors
involving effortful movement—“(pull) yourself up by the bootstraps,” “you gotta have
the willpower to dig yourself out,” “I get up and go out and do something, take care of
it.” If elderly persons view treatment of depression as primarily or exclusively their own
responsibility, they may be reluctant to disclose depression to physicians or other
professionals. The article also noted that most elderly persons were raised in a culture
where they had to pay up front for medical and other services, due to lack of Medicare
and Medicaid programs, and lack of health insurance offered as an employee benefit.
Further, most medical insurance policies have greatly reduced coverage for mental health
claims, when compared to physical ailments. This not only reduces financial incentive for
disclosure of depression, but the disparity in coverage may send a subtle message that
mental health issues are less socially acceptable. This may engender a habit of seeking
services for only the most urgent conditions.
Dementia may also lead to an inaccurate diagnosis of late-life depression (Burt &
Zembar, 1995; Manthorpe & Iliffe, 2006). In clinical practice and in epidemiological
studies of cognitive impairment, in order to render an accurate diagnosis of depression,
cognitive impairment needs to be taken into account. Likewise, when the main objective
is to render an accurate diagnosis for dementia, clinicians need to consider the presence
of depression. An accurate assessment of both cognitive status and depression help to

4
determine whether depression is the sole causal factor explaining impairment or whether
depression is part of the symptom profile of an individual with dementia. However, the
presence of cognitive impairment may affect depression reporting in some individuals.
For instance, some studies have found that elderly persons are not aware of their
depressive mood. This impaired insight seems to be linked to dementia. Several (Ott &
Fogel, 1992; Ott, Lafleche, Whelihan, & Buongiorno, 1996) but not all (Reed, Jagust, &
Coulter, 1993) studies have found a link between dementia severity and impaired
awareness of depression. This impaired awareness of depression may render depression
reports invalid, unless auxiliary informant report is available.
However, informant reports which are often used in clinical practice and in
epidemiological studies, suffer from some of the same confounders. They too may be
influenced by social stigma, and they too may experience lack of awareness of depressive
mood. In addition, informant reports can be influenced by the degree to which informants
are familiar with the subject, which is affected by the type of relationship to the subject,
the strength of that relationship, and geographic proximity to the subject.
Nevertheless, obtaining depression data from multiple sources is often preferable
to reliance on self-report alone. In epidemiological studies, where feasible, self-reports
and informant reports are often supplemented by physician evaluations, since physicians
can rely not only on written assessments but also on their own clinical judgment in
meeting with the subject. However, physician evaluations, considered by many to be the
“gold standard” in assessment of psychiatric conditions, are not economically feasible in
large-scale epidemiological studies. In such studies where thousands of participants must
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be evaluated, reliance on either self-report or informant report is common. While either
source of data alone is subject to the greatest risk of bias, a triangulation approach of
collecting data from multiple sources—subject and informant(s) may reduce this bias.
A small number of studies have addressed the strength of association between
self-report, informant report, and physician report. For instance, a study by Teri and
Wagner (1991) revealed that patients had lower depression ratings than caregivers (mean
patient =5.0 versus mean caregiver = 7.6, t(70) = 4.53, p < .0001, Cohen’s d = 0.38) and
clinicians (mean patient =5.0 versus mean clinician = 8.2, t[69] = 6.20, p < .0001,
Cohen’s d = 0.46, respectively), and that caregivers had lower depression ratings than
clinicians t(67) = 2.19, p <.05, Cohen’s d = 0.09. Few other studies addressed the extent
to which degree of cognitive impairment of the elderly subject and background factors on
the informant influence the strength of association.
Since physician evaluations of late-life depression are often not feasible in largescale epidemiological research, it is important to assess the strength of association
between subjects, informants, and clinicians, and to identify factors related to the
strongest association among these sources. Studies that have examined this have found
that subjects tend to be less likely to report depression than informants and clinicians.
However, caution is warranted in accepting these conclusions, since these studies are
sparse, and since they have all relied on clinic-based data, which may be biased toward
individuals who are more likely to report symptoms.
This thesis assessed the association between subject, informant, and clinician
reports of the subjects’ current depression status, and assessed factors that strengthened
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that association. Secondary analyses were conducted using data from a large, populationbased epidemiological study of dementia, the Cache County Study on Memory, Health,
and Aging, in which depression data were available from self-report, informant report,
and physician examination. Such enhanced understanding of the extent of consistency
between multiple reports will likely aid future community studies of geriatric depression.
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CHAPTER II
LITERATURE REVIEW
Public Health Significance of Geriatric Depression
This chapter reviews the literature regarding rating sources of late-life depression.
First, I demonstrate the public health impact of late-life depression by reviewing the
prevalence and incidence rates of late-life depression, and by reviewing the consequences
of late-life depression. I then discuss how subject characteristics, including cognitive
status, stigma, beliefs among the elderly, gender, medication side-effects and medical
comorbidities, and prior depression history can impact the accuracy of subjects’ reports
of depression. Then, I discuss the use of informants in diagnosing depression, and discuss
how informant and subject characteristics can affect informant reports of depression. In
addition, I discuss the use and feasibility of physician ratings of depression. Finally, I
review studies that have assessed agreement between sources.
Prevalence and Incidence Rates
Major and minor depression are common among the elderly, with communitybased prevalence rates ranging from 86% to 9.4% and 3.1% to 12.9%, respectively
(Beekman et al., 1995; Djernes, 2006; Eaton, Kalaydjian, Scharfstein, Mezuk, & Ding,
2007; Steffens et al., 2000). This is particularly concerning given the increasing
proportion of elderly persons in the United States. The Administration on Aging (2004)
predicts that the number of persons aged 65 and older will increase to 39 million by 2010,
to 53 million by 2020, and to 70 million by the year 2030.
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Consequences of Geriatric Depression
Late-life depression can severely affect quality of life. A study by Doraiswamy
and colleagues (2002) found that sufferers of late-life major depression reported
decreased general health perception, mental health, emotional functioning, social
functioning, and vitality. Late-life sufferers of depression are more likely to experience
withdrawal, apathy, lack of vigor (Adams, 2001), hopelessness (Christensen et al., 1999),
weight loss (Morley & Kraenzle, 1994), fatigue, some types of insomnia (Christensen et
al., 1999), are more likely to report pain, and are more likely to have a low perception of
their general health (Doraiswamy et al., 2002). Depression can also lead to suicide;
depression diagnosis is present in 80% of people aged 74 or older who commit suicide
(Conwell et al., 2002). This is particularly concerning given that the frequency of suicide
is almost twice as high in the elderly population than in the general population (Minino et
al., 2002).
Depression can also complicate cooccurring medical illness. Studies have found
depression to be a risk factor for mortality after myocardial infarction (Carney et al.,
2003), heart failure (among elderly women; Williams et al., 2002), and decreased
immune functioning (McGuire et al., 2002). Depression among the elderly is associated
with low bone-mineral density, a risk factor for osteoporosis (Robbins et al., 2001). In
addition, depression is associated with poor recovery from myocardial infarction (Ladwig
& Roll, 1994; Romanelli, Fauerbach, Bush, & Ziegelstein, 2002) and is associated with
poor recovery from interbody cage lumbar fusion surgery (LaCaille, DeBerard, Masters,
Colledge, & Bacon, 2005). Several studies, including a review by Jorm (2001), have

9
found that late-life depression leads to dementia (Dal Forno et al., 2005; Kessing &
Andersen, 2004; Shim & Yang, 2006; Steffens et al., 2004), while other studies found no
such effect (Chen et al., 1999; Dufouil et al., 1996; Henderson et al., 1997; Vinkers et al.,
2004).
Subject Factors Impacting Accuracy of Depression Diagnosis
Before late-life depression can be studied, it has to be accurately diagnosed.
However, several factors impede an accurate diagnosis of depression. Cognitive deficits
ranging from mild cognitive impairment (MCI) to dementia may result in unawareness of
depression symptoms, confounding the diagnosis of depression (McAvay, Raue, Brown,
& Bruce, 2005). Additionally, individuals may be reluctant to disclose depression
symptoms due to perceived negative social stigma, a misperception that depression is a
normative experience in late life, or if related to medication use, may also not be
reported. Each of these potential confounders is discussed in the following sections of
this literature review.
Depression Diagnostic Confounders:
Cognitive Impairment
Dementia as a depression diagnostic confounder. In clinical practice and in
epidemiological studies of cognitive impairment, in order to render an accurate diagnosis
of depression, cognitive impairment needs to be taken into account. For example, one
exclusionary criterion for major depression according to the fourth edition of the
Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric
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Association, 1994) is any medical condition that could explain the depressive symptoms
(e.g., dementia). Likewise, in order to render an accurate diagnosis for cognitive disorder,
clinicians need to consider the presence of depression. A fair degree of symptom overlap
can exist between depression and dementia. Nondepressed and depressed dementia
patients exhibit psychomotor slowing, emotional lability, weight loss, crying spells,
insomnia, pessimism, inability to verbalize affective state (McGuire et al., 2002), and
non-demented elderly people with depression tend to have difficulties with concentration,
speed of mental processing, and executive functioning (Alexopoulos, 2005). An accurate
assessment of both cognitive status and depression help to determine whether depression
is the sole causal factor explaining cognitive impairment or whether depression is part of
the symptom profile of an individual with dementia.
Mild cognitive impairment affects depression assessment. Level of cognitive
impairment has some impact on subjects’ ratings of depression. McAvay and colleagues
(2005) looked at whether agreement between subject and informant ratings of symptom
domains of depression, as measured by the Structured Clinical Interview for Axis I DSMIV Disorders (Spitzer, Gibbon , & Williams, 1995), differed depending on level of
cognitive impairment, as measured by a score out of 13 points possible of a subset of the
Mini-Mental State Examination, which measures orientation to time, orientation to place,
and recall of words. Lower scores on this measure indicate greater impairment. To look at
agreement between sources, the authors used the Kappa statistic (Fleiss, 1981). This is a
measure of interrater agreement of categorical data, and differs from traditional interrater
agreement statistics in that it corrects for chance. Kappa scores of 1 indicate perfect
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interrater agreement, and kappa scores  0 indicate no agreement other than that
expected by chance. Landis and Koch (1977) suggested the following strength of
agreement designations for Kappa values: < 0.0 = poor, 0-.20 = slight, .21 - .40 = fair,
.41-.60 = moderate, .61-.80 = substantial, .81-1.0 = almost perfect. According to this
statistic, agreement was lower for cognitive symptoms among subjects with more than
three errors on the orientation and recall questions (κ = .19 for patients with less than
three errors and κ = -.10 for patients with more than three errors). However, agreement
was not lower among subjects with more than three errors for somatic symptoms (κ = .30
for patient with < 3 errors, κ = .30 for patients with 3+ errors), psychological symptoms
(κ = .44 versus κ = .32), and suicidal symptoms (κ = .42 versus κ = .38).
To assess patterns of disagreement between the informant and subject, the authors
used the asymmetry index (AI), a log linear model technique that involves examining the
off-diagonal cell frequencies in order to assess whether informants were more likely to
report symptoms than subjects. AI scores above 1.0 indicated that the informant was
more likely to report symptoms, while AI scores below 1.0 indicated that the informant
was less likely to report symptoms. They found that informants were more likely than
patients to report psychological symptoms when patients made more than three errors
(AI = 1.2 for patients with < 3 errors, AI = 1.8 for patients with 3+ errors, p  .01 ), and
informants were less likely than patients to report suicidal symptoms when patients made
less than three errors (AI = 0.3 for patients with < 3 errors, AI = 1.4 for patients with 3+
errors).
Knauper and Wittchen (1994) conducted a study assessing whether differences in
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working memory capacity account for changes in self-reported depression. Differences in
working memory capacity were measured by a listening span task described by Daneman
and Carpenter (1980). This task assesses ability to keep verbal items in working memory
while performing memory search, comprehension, and judgment tasks. Self-reported
depression was assessed using the Composite International Diagnostic Interview (CIDI;
Wittchen & Semler, 1991), a modified and expanded version of the Diagnostic Interview
Schedule (DIS; Robins, Helzer, Ratcliff, & Seyfried, 1982). They found a negative
relationship between working memory capacity and the number of physical symptoms of
depression endorsed by the subject (r = -.34, df = 61, p  .004). Using a two-step
hierarchical regression analysis in which the number of physical symptoms of depression
was the outcome variable, the authors found that working memory capacity remained
significant after adding age to the model (Age: beta = .18, F(1,61) = 1.82, p  .18;
Working memory: beta = -.27, F(2,60) = 3.99, p  .05), suggesting that the effect of
working memory capacity on the number of physical symptoms of depression reported
was robust to age. These findings support the conclusion that cognitive impairment may
increase the number of self-reported physical symptoms of depression.
Depression Diagnostic Confounders:
Perceived Negative Repercussions
of Disclosure
Elderly persons may be reluctant to disclose depression because they believe that
doing so may have negative repercussions. A study by Roeloffs and colleagues (2003)
looked at the perceived negative effect of depression. Participants in this study were
selected from clinics across several states. Forty-four percent of participants were
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between the ages of 18 and 41, and 56% of participants were 41 years or older. Subjects
were considered depressed if they scored positive on a five-item screening test based on
the World Health Organizations Composite International Diagnostic Interview 2.1, 12
month version (CIDI-12; Wittchen & Semler, 1991) and had depressive symptoms in the
past month. The authors asked participants if they thought that disclosure of “a recent
history of depression” (p. 312) would negatively affect their ability to get a job, to change
health insurance policies, and to maintain friendships. They also asked them similar items
about disclosure of HIV, hypertension, and diabetes. A high percentage of participants
expected disclosure of depression to negatively affect some aspect of their lives. Sixtyseven percent of participants expected disclosure of depression to negatively affect ability
to gain employment, 59% expected it to affect their ability to obtain health insurance, and
24% expected it to negatively affect their friendships.
In bivariate analyses, older age, lower education, employment, social support,
diagnosis of major depression, increased number of chronic medical conditions, and
clinic location (the researchers obtained participants from clinics located in several states)
were all related to the belief that depression disclosure would impact at least one area of
life. Factors that were not significant in bivariate analyses included: substance misuse,
hazardous drinking, and health insurance status. Using a multivariate model that
controlled for socio-demographic variables and severity of illness, the authors found that
the younger age group (ages 17-34) was less likely to expect disclosure to negatively
affect employment than the middle age group (ages 35-59; OR = 0.64, p = .035). The
oldest age group (60+ years old) did not differ from the middle age group in this area.
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Age was not related to perceived effect of disclosure on health insurance or friendship.
Perceived negative effect of disclosure on health insurance and friendship was higher in
participants with three or more chronic medical conditions (OR = 1.79, p = .30 and
OR = 1.50, p = .046, respectively). Women were more likely to perceive a negative effect
of disclosure on jobs than men (OR = 3.70, p = 0.027), but a female gender by social
support interaction term indicated that women with social support were less likely to
perceive a negative effect of disclosure on jobs than women without social support
(OR = 0.70, p = 0.039). These findings suggest that some persons, particularly the
middle-aged and elderly, females, and those with a greater number of medical conditions,
are more likely to report depression symptoms because of concerns about employment,
health care coverage, and friendships.
The relationship between perceived negative effects of disclosure, utilization
(mental health specialty visits, primary care visits for emotional reasons, primary care
medical visits, and total visits) and unmet need were equivocal. Regression models using
perceived negative effects of disclosure as a predictor and utilization of unmet need as a
dependent variable and which adjusted for depression severity found perceived negative
effects of disclosure on employment to be related to less unmet need for mental health
services (OR = 0.24, p < .01). Perceived negative effects of disclosure on friendship was
related to more unmet needs for mental health services (OR = 1.51, p = .037), and
perceived negative effects of disclosure on health insurance was related to more medical
visits (B = 0.89, p = .02) and more receipt of appropriate treatment (OR = 1.49, p = .03).
There were no other statistically significant relationships between perceived negative
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effects of disclosure and unmet needs/utilization variables. These findings suggest that
perceived negative effects of disclosure have diverse effects on health care utilization.
Depression Diagnostic Confounders:
Belief That Depression is a “Normal”
Part of Aging
In addition to lack of awareness and stigma, older adults (and their family
members) may even consider depressed mood as a normal part of aging. For instance, a
study by Farrer, Leach, Griffiths, Christensen, and Jorm (2008) found that among
participants aged 70 or older, fewer persons (41.5%) identified depression in a vignette
depicting a 30 year old man or woman with depression than those in other age categories:
18-24 years (71.7%, z = 4.77, Cohen’s h = .64), 25-39 years (70.8%, z = 5.76, Cohen’s
h = .61), 40-54 years (67.4%, z = 5.0, Cohen’s h = .53), and 55-69 years (64.9%, z =4.3,
Cohen’s h = .50).
Presence of depression may also influence the likelihood of reporting depression,
although findings conflict as to whether the presence of depression makes a person more
or less likely to report symptoms. Allen and colleagues (1998) found that older persons
with depression, as measured by the Geriatric Depression Scale (MD-Self; Yesavage et
al., 1982), were less likely than older persons without depression to report that they
would approach anyone (χ2 = 8.7, Fisher’s exact test p < 0.03), or that they would
approach a spouse (χ2 =5.9, p < 0.03), if suffering from depression. A study by O’Connor,
Rosewarne, and Bruce (2001) found that severity of depression, as measured by the Scale
for Depressive Symptoms (SDS; Henderson, Jorm, Mackinnon, & Christensen, 1993)
which measures dysthymia, depressive episode, and major depressive disorder, was
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independently and positively related to self-rated likelihood of reporting depression
symptoms to a general practitioner (β =.143, p < .00005). Past psychiatric contact and
female gender were also independently and positively related to self-rated likelihood of
reporting depression symptoms to a general practitioner (β = .589, p < .00005 and
β = .241, p = .03, respectively).
Depression Diagnostic Confounders:
Gender
Studies have found that depression is more common among females. In a review
of studies assessing the prevalence of depression among older persons, Djernes and
colleagues (2006) found that older females were more likely to have depression than
older males (odd ratios: 3.4 to 1.3). However, several lines of evidence suggest that this
increased prevalence may be due in part to reporting artifact. Hinton, Zweifach, Oishi,
Tang, and Unutzer (2006) found, for example, that older males with major depression or
dysthymia, as measured by the Structured Clinical Interview for DSM-IV (SCID; Spitzer,
Williams, Gibbon, & First, 1992), were less likely to seek treatment than older females
with major depression or dysthymia. In a series of multiple regression models that
controlled for marital status, minority status, presence of two or more prior depression
episodes, presence of suicidal thoughts, presence of cognitive impairment (as determined
by a screening question), depression score, and site from which the participant was
recruited, the researchers found that men were less likely to use any antidepressant in the
previous three months (OR = 1.42, p = 0.0038), to receive any depression care in the
previous three months (OR = 1.43, p = 0.0031), to receive any depression care throughout
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their lifetime (OR = 1.74, p < 0.0001), or to receive potentially effective depression
treatment, defined as at least four sessions of psychotherapy or at least two months of
antidepressant usage (OR = 1.69, p = 0.0002). Older males may avoid treatment because
they are reluctant to admit that they have depression symptoms.
Estimates of gender disparities in depression may also be distorted because of
different symptom patterns among males and females. For instance, Hinton and
colleagues (2006) found that depressed older men were less likely than depressed older
women to report that they felt depressed or down (men: 39% versus women: 47%, χ2 =
21.24, p < 0.001), that they had lost interest in the things they enjoyed (men: 37% versus
women: 42%, χ2 = 7.14, p = 0.008), that they felt fatigued (men: 62% versus women:
67%, χ2 = 7.49, p = 0.008), and that they had appetite problems (men: 34% versus
women: 41%, χ2 = 14.36, p < 0.001). Men are also more likely than women to commit
suicide. A study by the Centers for Disease Control and Prevention (Minino et al., 2002)
found that among persons of all ages suicide rates were four times higher among men
than among women (18.1 per 100,000 in men versus 4.0 per 100,000 in women). Some
authors have argued that current depression instruments reflect symptom patterns more
closely associated with the female gender. If this is so, current depression instruments
may underestimate depression among males (Möller-Leimkühler, 2002).
Hinton and colleagues (2006) also found that men express depression differently.
In semistructured interviews of primary care physicians, depression care managers (nine
nurses and two psychologists), and research assistants, respondents expressed a belief
that men were less likely to express the emotional aspects of depression. For example,
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one physician said, “Women in general are much more likely to present with mood
symptoms saying they are feeling depressed or feeling anxious or nervous. I think men in
general, especially older men, are much less likely to mention those red flag kind of
words.” Respondents had various explanations for this discrepancy. Some stated that men
did not express the emotional aspects of depression because they do not recognize them,
while other respondents stated that they purposefully tried to hide them from others.
In addition, some respondents stated that men were less willing to accept a
depression diagnosis. For example, one primary care physician stated, “They [men] just
do not go with the labels. They’ll say, no I’m not sleeping well, I have aches and pains. It
seems to be a leap for them to accept depression treatment for that. The men recognize
the symptoms, but they still do not think it is them.” The study found that this reluctance
to admit depression may be due to traditional conceptions of masculinity. Some
respondents described a subgroup of men who believed that men should be selfsufficient, stoic, and tough. These men may be reluctant to express or report symptoms of
depression such as worthlessness, helplessness, and sadness for fear of seeming unmanly.
Depression Diagnostic Confounders:
Medication Side-Effects and
Medical Comorbidities
Comorbid medical conditions may also confound the diagnosis of depression
among the elderly when using self-report or informant report (Alexopoulos, 2005).
Depression can be a side effect of some medications, including beta-blockers
(Alexopoulos, 2005; D.C. Steffens, personal communication, March 30, 2009) and some
steroids (Brown & Suppes, 1998; D.C. Steffens, personal communication, March 30,
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2009). Depression can also be a side effect of interferon (Zdilar, Franco-Bronson,
Buchler, Locala, & Younossi, 2000; D.C. Steffens, personal communication, March 30,
2009), although this drug is rarely used. If such side effects were anticipated, the
depressed mood may likewise be considered normal ‘background’ experience and
nothing noteworthy.
As noted by several authors (Alexopoulos et al., 2002; McAvay et al., 2005)
elderly patients are more likely to report symptoms of medical illness and to omit
symptoms of mental illness when communicating with their physicians, which makes a
depression diagnosis less likely. This is likely to occur in patients with medical
conditions related to depression. These include vascular conditions such as heart attack
(Alexopoulos, 2005), stroke (Yamaguchi, Kobayashi, Koide, & Tsunematsu, 1992),
hypertension (Jonas, Franks, & Ingram, 1997), type II diabetes (Anderson, Freedland,
Clouse, & Lustman, 2001), and hypercholesterolemia (Van Melle et al., 2006), as well as
other conditions such as viral infection, endocrinopathy, malignant disease, and
metabolic disorders (Alexopoulos, 2005). The symptoms of some medical conditions
mimic the symptoms of depression. For instance, the symptoms of apathetic delirium
include reduced speech, withdrawal, and nonspecific dysphoria (Armstrong, Cozza, &
Watanabe, 1997). Some elderly persons deny having depressed mood but report a lack of
feeling or mood or a lack of interest in normally pleasurable activities. This tendency of
elderly persons to omit the affective symptoms of depression has been described as
“depression without sadness” (Gallo & Rabins, 1999).
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Depression Diagnostic Confounder:
Prior Depression History
Depression incidence is higher among persons with a prior history of depression.
A study by Norton and colleagues (2006b) found that incidence of major depression per
1,000 person years, as measured by the Diagnostic Interview Schedule (DIS), was greater
for participants with a prior minor depressive episode (23.0) than it was for participants
without a prior minor depressive episode (8.32). A study by Murphy and colleagues
(2002) was consistent with this finding. They found that the incidence of major
depression per 1,000 person years, as measured by the DIS, was much higher for
participants with a prior history of dysthymic disorder (210.5), than it was for participants
in a reference category (4.0). This relationship is likely due to the chronic nature of
depression. However, it may also be a reporting artifact; the relationship between
incidence and prior history may indicate a greater willingness to report symptoms among
some persons.
Informant-based Report of Geriatric Depression
Often, collateral informants are also queried about depression symptoms of older
adults, given that they are typically used as confidantes and provide an important
additional perspective. In a mixed methods study of current and recent sufferers of latelife depression, Piercy, Norton, and Cloward (2007) found that older adults’ primary
source for emotional support for depression was close family members. In fact, most
expressed reluctance to seek emotional help from or disclose depressive symptoms to
anyone but close family members. This suggests the need for a more family-systems
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approach in both clinical practice and epidemiologic studies, in which information about
the older adult’s depressive symptoms is obtained from both self-report and through
family members. However, informant reports used in clinical practice and in
epidemiological studies suffer from some of the same confounders; they too may be
influenced by perceived social stigma, and they too may experience lack of awareness of
depressive mood.
Various types of informants can be seen in the research literature on geriatric
depression. McAvay and colleagues (2005) used spouses, children-in-law or children,
siblings, friends, and “other relatives” as informants of depression. In other studies of
informant reports of depression informants were described simply as “caregivers” (Teri
& Wagner, 1991). A study by Castle (2005) on informant reports of patient care
satisfaction used “family members.” Some studies of informant reports of depression
used employees as informants (Bourgeois, Dijkstra, & Hickey, 2005; McAvay et al.,
2005). A study by Ott and colleagues (1996) on informant reports of memory and
functional decline also used employees as informants.
As subjects get older, the availability of the spouse as the informant decreases due
to mortality. Because of this, researchers often use adult children, friends, and other more
distant relatives as informants. These informants are often less knowledgeable of the
subject’s affective state than the spouse. In addition, informant reports of the subject’s
affective state can be influenced by other factors, such as the number of years the
informant has known the subject, and frequency of contact with the subject, since these
factors affect the amount of interaction between the informant and the subject.
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Clinician Evaluation of Depression
Because of these limitations, self-reports and informant reports are often
supplemented in research studies by physician evaluations, since physicians can rely not
only on written assessments but also on follow-up questioning, observations, and their
own clinical judgment in meeting with the subject. However, physician evaluations,
considered by many to be the “gold standard” in assessment of psychiatric conditions, are
simply not economically feasible in large-scale epidemiological studies. In such studies
where thousands of participants must be evaluated, reliance on either self-report or
informant report is common. While either source of data alone is subject to the greatest
risk of bias, a triangulation approach of collecting data from multiple sources (subject and
informant) reduces this bias.
Several instruments can be used to assess late-life depression. The Patient Health
Questionaire-9 (PHQ-9; Kroenke, Spitzer, & Williams, 2001) is a nine-item depression
instrument that can be self-administered. This instrument uses a symptom checklist to
diagnose major depression as well as subthreshold depression, which it calls “other
depressive disorder.” The Geriatric Depression Scale (Yesavage et al., 1982) is a 30-item
self-report measure of depression specifically designed for the elderly. Like the PHQ-9,
the GDS uses a symptom checklist to diagnose depression. Informant report may come
from an instrument such as the Neuropsychiatric Inventory (NPI; Cummings et al., 1994).
The NPI is an informant-based assessment and is specifically designed for persons with
dementia. The NPI uses semi-structured interviews to measure ten behavioral domains,
including depression/dysphoria. Like the GDS and PHQ-9, the NPI uses a symptom
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checklist to assess depression. The NPI also asks about the frequency and severity of
depression symptoms.
Association of Depression Reports between Multiple Sources
There have been very few published studies that have addressed the extent of
association between self-report, informant report, and clinician reports of geriatric
depression. Each of these studies and their limitations are summarized below.
Self-Report versus Informant-Report
of Depression
McAvay and colleagues (2005) looked at the association between patient and
informant reports of depression. Patients in this study were recruited from medical home
care centers. Mean patient age was 78 years (range 65-100). In a study of 539 generally
cognitively normal patients from medical home care, 430 were able to nominate “a
family member or close friend” (p. 509) to be an informant. Informants in this study
included spouses (40.6%), children or children-in-law (36.9%), 17 siblings or siblings-inlaw (4.8%), other relatives (5.4%), friends (11.8%), and 2 paid employees (0.6%). Most
of the informants were female (73%). Patients and informants were interviewed using the
Structured Clinical Interview for Axis I DSM-IV Disorders (Spitzer et al., 1995). The
authors postulated that the association between sources of information would depend on
the type of depression symptomatology, as well as level of cognitive impairment,
informant age, patient and informant gender, and whether or not the informant had daily
contact with the patient. Types of depression symptomatology included somatic
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symptoms (decreased appetite or weight loss, increased appetite or weight gain,
psychomotor agitation or psychomotor retardation, insomnia or hypersomnia, fatigue or
loss of energy), cognitive symptoms (indecisiveness or diminished ability to concentrate
or think), psychological symptoms (diminished interest or pleasure, depressed mood,
worthlessness, inappropriate guilt), and suicidal symptoms (thoughts of death, suicidal
ideation). To compute scores for each symptom domain, the authors counted the number
of symptoms endorsed in each (somatic: 0-3+, cognitive: 0-1, psychological: 0-2+,
suicidal: 0-1). Cognitive functioning was assessed using a score out of 13 total points
possible of a subset of the Mini-Mental State Examination which measured orientation to
time, orientation to place, and recall of words (MMSI; Folstein, Folstein, & McHugh,
1975).
In general, agreement was fair or poor in all four depression domains. It was
found that informants were more likely than patients to report psychological and
cognitive symptoms (asymmetry index [AI] =1.4, p  .001, and AI = 1.7, p  .05,
respectively; κ = .41 and κ =.09, respectively) and that informants were less likely than
patients to report suicidal symptoms (AI =.52, p  .10, κ =.41). Disagreement was poor for
the somatic domain (κ =.31, no AI reported) and did not follow a definite pattern.
Level of cognitive impairment had some impact on agreement. Kappa showed
mostly agreement. Kappa was lower in the cognitive domain among subjects with more
errors on the orientation and recall questions (κ = .19 for patients with less than three
errors and κ = -.10 for patients with more than three errors). However, kappa was not
lower among subjects with more errors in the somatic (κ = .30 for patient with < 3 errors,
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κ = .30 for patients with 3+ errors), psychological (κ = .44 for patient with < 3 errors,
κ = .32 for patients with 3+ errors), and suicidal domains (κ = .42 for patient with < 3
errors, κ = .38 for patients with 3+ errors). Less agreement was shown in the AI.
Informants were more likely than patients to report psychological symptoms when
patients made more than three errors (AI = 1.2 for patients with <3 errors, AI = 1.8 for
patients with 3+ errors, p  .01 ), and were less likely than patients to report suicidal
symptoms when patients made less than three errors (AI = 0.3 for patients with < 3
errors, AI = 1.4 for patients with 3+ errors, p  .05 ).
Informant age had some effect on agreement. It did not affect kappa agreement on
any of the domains. However, the AI showed that agreement was affected by informant
age. It was found that younger informants (23 to 64 years of age) were more likely than
older informants (65 to 95 years of age) to report more psychological symptoms than
patients (AI = 1.6 versus 1.1, respectively), and to report more cognitive symptoms than
patients (AI = 3.7 versus 0.8, respectively). AI did not vary by age for the somatic and
suicidal domains.
Although the researchers found that patient gender, informant gender, and
frequency of contact with the patient affected agreement, they were unable to make any
certain conclusions about the effects of these factors because of the high correlations
between them. For instance, the authors found that 90% of male patients used female
informants, whereas only 59% of female patients had female informants. Because of this,
the authors could not conclude whether differences in AI among male and female patients
were due to patient gender or to informant gender.
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Snow and colleagues (2005) found that discrepancy between patient reports and
informant and clinician reports of depression were not due to dementia per se, but to
patient awareness of dementia deficits. In this study, researchers conducted two
hierarchical regression models. In one model, severity of cognitive impairment (as
measured by the cognitive subscale of the Alzheimer’s Disease Assessment Scale),
physical illness, functional status, caregiver burden, clinician reports of depression
(Cornell Scale for Depression in Dementia), and awareness of dementia were entered as
predictors, and patient/informant depression discrepancy scores (difference between the
summed informant rated Geriatric Depression Scale scores and the summed patient-rated
GDS scores) were entered as the dependent variable. Informants in this study were
relatives, friends, and caregivers and had at least four hours of contact a week with the
patient each week. Although the authors did not include gender in their analyses, it
appeared to be an important factor. Demographic information reported in the study
revealed that females may have been less likely to be diagnosed with only depression;
whereas the control, dementia only, and depression and dementia groups were 52%, 42%,
and 45% female, respectively, the depression only group was only 23% female.
The authors found that among patients with and without a previous diagnosis of
dementia, awareness of dementia was the only factor that predicted the discrepancy
between patient and informant depression scores (dementia sample: F[7,65] = 3.63,
informant-patient DDS discrepancy β = 0.60, p < .005; nondementia sample: F[7,54] =
4.08, informant-patient DDS discrepancy β = 0.57, p <.001). A similar model used
severity of cognitive impairment, physical illness, functional status, informant-rated GDS
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scores, and awareness of dementia (as measured by the patient-clinician discrepancy
score on the DDS) as predictors and patient-clinician depression discrepancy scores
(difference between the summed clinician-rated Cornell Scale for Depression in
Dementia scores and the summed patient-rated GDS scores) as the dependent variable.
Findings were similar to those in the first model; among patients with a previous
diagnosis of dementia, awareness of dementia deficits was the only factor that predicted
the discrepancy between patient and clinician depression scores, F(6,54) = 2.92,
informant-patient DDS discrepancy β = 0.32, p < .05.
The authors also found, in turn, that awareness of dementia deficits depends on
dementia diagnosis. Patient-informant discrepancies on the DDS indicated that patients
previously diagnosed as having dementia or as having both dementia and depression were
significantly more likely to report fewer dementia symptoms than were controls or
patients previously diagnosed with depression only (mean discrepancies  SD:
controls; -0.54  0.56, depression only; -0.54  0.81, dementia only; 0.43  0.99,
depression and dementia; 0.26  1.33; scores above 0 indicated that the informant rated
depression higher, while scores below 0 indicated that the patient rated depression higher;
controls versus dementia only: p < .01, controls versus depression and dementia: p < .05,
depression only versus dementia only: p < .01, depression only versus depression and
dementia: p < .05). Patient-clinician discrepancies on the DDS revealed similar findings.
Patients previously diagnosed as having dementia or having both dementia and
depression were significantly more likely to report fewer dementia symptoms than were
patients previously diagnosed with only depression (mean discrepancies: depression only;
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-1.23, dementia only; 0.51, depression and dementia; 0.08; depression only versus
dementia only: p < .001, depression only versus depression and dementia: p < .01).
Self-Report Versus Physician Rating
of Depression
Ott and Fogel (1992) looked at the association between self-report, caregiver
report, and clinician report of depression. In this study the authors used the Geriatric
Depression Scale (Yesavage et al., 1982) to assess self-reports of depression, the HAM-D
(Hamilton, 1960) to measure caregiver reports of depression, and the Cornell Depression
Scale for Depression in Dementia (Alexopoulos, Abrams, Young, & Shamoian, 1988) to
measure clinician reports of depression. The study also looked at how awareness of
dementia affected the strength of association between rating sources. Researchers
assessed impaired insight of dementia using a self-report questionnaire that asked if
patients had (a) awareness of the situation, (i.e., reason for the office visit), (b) awareness
of memory impairment, (c) awareness of impairment in activities of daily living, and (d)
awareness of progression of deficit. Each question was scored on a 0-2 scale, with a total
possible range of 0-8. Higher scores on this measure indicated less insight. Dementia
severity was also assessed in order to ascertain its effect on the strength of association.
Three scales were used for this: The Clinical Dementia Rating Scale (Morris, 1993)
possible range 0-3, higher scores indicate greater impairment), the MMSE (range 0-30,
lower scores indicate greater impairment), and the brief Orientation-MemoryConcentration Test (Katzman et al., 1983) possible range 0-28, higher scores indicate
greater impairment). 41 of the 50 participants in the study obtained MMSE scores  26 .
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Mean Clinical Dementia Rating Scale score was 1.1 (SD = 0.7), mean MMSE score was
20.3 (SD = 7.5), and mean OMC score was 13.7 (SD = 8.2), indicating a range of
cognitive impairment. Of the 50 participants, 23 were male, and 27 were female. Since
caregiver depression could affect ratings of patient depression, researchers also
administered the GDS to caregivers.
Researchers found that caregiver depression did not affect ratings of patient
depression and that dementia and impaired insight of dementia decreased the association
between patient and clinician reports of patient depression. GDS scores of caregiver
depression correlated poorly with clinician-rated COR scores and caregiver-rated HAMD scores (HAM-D: r = 0.202, p = 0.245; COR: r = 0.266, p = 0.123), indicating that
caregiver depression did not affect caregiver ratings of patient depression. The HAM-D
and COR correlated well (r = 0.92, p < 0.0005), indicating congruence between caregiver
and clinician reports. Insight and cognitive impairment were strongly related (insight and
MMSE: r = -0.67, p < 0.005; insight and OMC; r = 0.64, p < 0.005). GDS and COR
scores were only moderately associated (r = 0.40, p = .0004). This correlation was even
lower among patients with MMSE scores less than 22 and insight scores greater than two
(r = 0.15, p value not reported). In addition, a multivariate analysis using MMSE score,
clinical dementia rating, diagnosis of AD, insight score, history of depression, age, sex,
and education as predictor variables revealed clinical dementia ratings and insight scores
to be the only significant predictors of GDS-COR discrepancy scores (clinical dementia
ratings: coefficient = -3.12, t = -2.38, p = 0.02; insight score: coefficient = -1.39, t
= -4.25, p < 0.0005). MMSE scores approached significance (coefficient = -0.16,
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t = -1.21, p = 0.23).
Self- Versus Informant- Versus
Clinician Ratings
Teri and Wagner looked at the association between AD patients, informants, and
clinicians (Teri & Wagner, 1991). To do this they obtained three separate total scores on
the HAM-D (Hamilton, 1960); one using self-report information only, one using
caregiver information only, and one in which the geriatricians used both the self-report
and caregiver report as well as their own behavioral observations to come up with a
score. The geriatrician used this score and DSM-III criteria to diagnose depression. All
75 patients in the study had DSM III-R diagnosis for primary degenerative dementia of
the Alzheimer’s type (AD). Participants in this study were predominantly female (68%).
Caregivers consisted of spouses (51%), daughters (27%), sons (13%), and others (9%).
The authors found that Alzheimer’s patients diagnosed as depressed according to the
clinical diagnosis reported less insomnia, change in interests, psychic anxiety, and
somatic energy change than did the caregiver or the clinician, and that they reported less
depressed mood, suicidal feelings, and somatic anxiety than the caregiver. Alzheimer’s
patients without depression exhibited similar findings; they reported less depressed mood
and less change in interests than the caregiver or the clinician, and they reported less
agitation, psychic anxiety, and somatic energy change than the clinician. It also found
that caregivers reported less agitation and somatic energy change than did the physician.
In addition, the study found that severity of dementia did not affect rating. Few other
studies addressed the extent to which degree of cognitive impairment of the elderly
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subject and background factors on the informant influence the association between
multiple sources.
Conclusion
Depression among the elderly is a major public health concern. Accurate
diagnosis of depression is needed in clinical practice and in epidemiological studies of
cognitive impairment. Research literature reveals that, in general, subjects are less likely
to report depression than other sources. Several factors contribute to this. Some studies
have found that cognitive impairment affects patient self-reports of depression, with
patients with cognitive impairment reporting less depression than informants or
physicians. Other studies have found that social stigma inhibits patients from fully
disclosing depression. Social stigma may affect informant reports of depression as well.
Presence of depression itself tends to decrease reports of depression. Since depression is a
side effect of some medications and medical conditions, patients and informants may
view depression as “normal” and not noteworthy. The literature on the accuracy of
informant reports is mixed. Some evidence suggests that type of informant and informant
age affects depression reports. However, very few studies have explored how informant
factors affect depression reports. Although physician evaluations are free of much of the
reporting bias inherent in self-reports or informant reports, they are often not feasible in
epidemiological studies.
The preceding findings lead to the following research questions.
1. What is the strength of association between subject self-report, informant
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report, and physician reports of major depression?
2. Is the association between subject self-report and physician report of major
depression, and the association between subject self-report and informant report of major
depression, affected by subject characteristics including: subject age and gender, degree
of cognitive impairment, medical comorbidities, use of medications with depressogenic
side effects, or prior history of major depression?
3. Is the association between informant report and subject self-report of major
depression, and the association between informant report and physician report of major
depression, affected by informant characteristics including: informant age, informant
relation to subject, how long the informant has known the subject, or by frequency of
contact with the subject?
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CHAPTER III
METHODS
This chapter describes an extant dataset made available for this thesis project.
Subject selection, procedures, measurement and analyses relating to stated research
questions will also be described, after first providing a brief overview of the original
study.
Overview of the Cache County Study on Memory
Health and Aging
The Cache County Study on Memory Health and Aging (CCSMHA) is a large,
population-based epidemiological study of dementia. Funded continuously since 1994 by
the National Institute on Aging (R01-AG-11380), it was designed to study prevalence
and incidence of Alzheimer’s disease (AD) and other dementias, and the influence of
genetic and environmental factors, and their interactions, on disease risk. This was
accomplished by a large-scale data collection effort at each of four triennial “waves” of
ascertainment of dementia and depression (an important potential confounder when
diagnosing dementia). Data sources included self-report, informant-report, and physician
assessment. Because all of the depression measures required for this thesis project were
not collected until Waves 3 and 4, data derive from these two study waves, with the
exception being depression data from Waves 1 and 2 used only to establish prior
depression history.
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Subjects
The CCSMHA is a population-based study that sought to enroll 100% of eligible
residents of Cache County aged 65 years or older as of January 1, 1995. The final sample
for this thesis project included 1,481 subjects who completed a clinical assessment
(hereafter referred to as the “CA visit”) in either Wave 3 or 4, and 148 subjects who
completed a physician assessment (hereafter referred to as the “MD visit”) in either Wave
3 or 4. What follows is a description of the final derivation of this sample, beginning
from the original eligible pool of individuals.
The original list of eligible individuals came from Medicare enrollee lists from the
Health Care Financing Administration (HCFA) of those with permanent residence in
Cache County, Utah, who were aged 65 years or older as of January 1, 1995. A small
number were recruited from other sources such as local publicity efforts. Eligible
participants totaled 5,677 when fieldwork began in April 1995. Total number of
participants enrolled in the study was 5,092. The high participation rate of 90% greatly
reduced non-response bias (Norton, Breitner, Welsh, & Wyse, 1994), which would tend
to underestimate prevalence and incidence rates of both dementia and depression, owing
to the higher probability of those who refuse participation to have greater cognitive
impairment, to be older, and have less education, and to be depressed, all of which factors
being related to dementia risk (Welsh-Bohmer et al., 2006).
Cache County was selected for this study for several reasons. It was reported to
have the highest longevity rate in the U.S. (Murray, Michaud, & McKenna, 1998). Based
on 1990 Census data, women’s life expectancy was 88.1 years (compared to U.S. rate of
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78.5 years) and men’s life expectancy was 85.7 years (compared to U.S. rate of 71.5
years). Greater longevity substantially improves a study’s ability to examine prevalence
and incidence rates of conditions that afflict those in older age groups such as dementia.
These reduced mortality rates are in part due to a religious denomination—The Church of
Jesus Christ of Latter-day Saints—which proscribes alcohol and tobacco use. Of the local
population of older adults, 91% are members of this religion (Norton et al., 2006a). The
population of Cache County is associated with reduced rates of alcohol and tobacco use,
resulting in reduced rates of several common cancers, hypertensive and atherosclerotic
cardiovascular disease, and lower rates of mortality before age 85. These characteristics
also help simplify the differential diagnosis of dementia. This population is also
associated with larger families, which provides more opportunities for informant
interviews. Higher rates of education found in Cache County also simplified the
diagnosis of dementia; since subjects typically started higher on cognitive screening
instruments, declines over time could be more readily detected. In addition, Cache
County has low rates of in and out migration, which leads to greater participant
consistency. This consistency is of great benefit in longitudinal studies.
Of the population of persons 65 years or older identified in Cache County, 542
refused interviewing, 26 were deceased, and 17 could not be located, leaving 5,092
participants. Of these, 371 were identified in Wave 1 as having dementia, leaving 4,721
persons who were eligible for the Wave 2. Of these 4,721 persons, 594 were deceased,
159 moved away, 546 refused interviewing, and 15 could not be located, leaving 3,407
persons who participated in Wave 2. Wave 2 identified 204 of these persons as having
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dementia, leaving 3,203 eligible for Wave 3.
In Wave 3, 2,324 persons participated in the screening assessment, while 97
persons were deceased, 75 had moved away, 354 refused, 25 persons could not be
located. The researchers selected participants for the CA visit if at the screening
assessment the participants were 85 years of age or older, if they had screened positive
(score of 90 or lower) on the Modified Mini-Mental State Examination (3MS; Teng &
Chui, 1987), or if they were selected to be part of a designated control panel (details
provided below). Of the 2,324 completing screening in Wave 3, 1,593 were selected for
the CA (68.5%), and of these 1,224 (76.8%) completed the CA, while 74 were deceased,
24 had moved or were not located, and 271 refused. Participants that were given a
provisional diagnosis of dementia or “mild/ambiguous” impairment (subsyndromal AD)
at the case staffing review of the CA visit were selected for the physician evaluation. Of
the 1,229 completing the CA visit, 423 participants were selected for the MD visit
(34.6%), and of these, 357 (84.4%) completed the MD visit27 were deceased, 4 had
moved or could not be located, and 35 refused.
To ensure independence of observations, only one set of data was used for each
subject. If a subject completed the CA and/or MD visit at both Waves 3 and 4, only the
data from Wave 3 were used (this protocol is described in more detail in Appendix B,
along with analyses to determine similarity across several demographic measures
between subjects whose data came from Wave 3 versus Wave 4). As a result of this
protocol, this study utilized data from the 1,229 persons who participated in the Wave 3
CA visit and an additional 252 who did not participate in Wave 3 CA visit but did
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participate in Wave 4 CA visit (total with data from the CA is n = 1,481). In analyses of
MD visit data, this study utilized data from 124 persons who completed Wave 3 MD visit
measures and an additional 24 persons who completed the measures at the Wave 4 MD
visit.
Procedures
Of primary interest are procedures involved in the collection of depression data
analyzed in the present work. However, the sample for this thesis project was comprised
of the subset of participants who completed the more in-depth clinical data gathering
portion of the CCSMHA. Therefore, what follows next is a detailed description of
procedures employed to determine this final sample, including procedures for the CA and
MD visits where depression data were gathered.
The CCSMHA study included four ascertainment “waves,” spaced approximately
3-4 years apart. The first wave was designed to identify prevalent cases of dementia and
later waves to identify incident cases. At each wave, participants completed a three-stage
dementia screening protocol, which consisted of a cognitive screening, a clinical
assessment (CA visit), and a physician evaluation. Ascertainment protocol was modified
in Waves 3 and 4. Given that these are the waves from which data was utilized for this
thesis, protocol for these waves are described here.
In the first stage, researchers conducted screening interviews to collect both
cognitive data and information on interval putative risk factors. Cognitive screening
consisted of the 3MS (Teng & Chui, 1987). The 3MS is a 100-point adaptation of the
Mini-Mental State examination (MMSE; Folstein et al., 1975) that increases the
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instrument’s floor and ceiling. Researchers further adapted the 3MS for epidemiological
studies (Tschanz et al., 2002), including alternate versions of the test that included two
new word list recall tasks in addition to the original tasks. Informants (typically spouses
or other family members) were used to collect risk-factor interview data if the subject (a)
could not complete the 3MS, (b) scored below 15 out of 20 on a set of orientation
questions asked at the beginning of the interview, (c) scored below 60 on the 3MS, or (d)
was for any other reason deemed by the clinical judgment of the interviewer as
unreliable. In all other cases, subjects gave their own risk factor interview data, including
information about depression using a modified version (Steffens et al., 2000) of the
Diagnostic Interview Schedule’s Depression Scale (DIS; Robins, Helzer, Croughan, &
Ratcliff, 1981). Informants were given the Informant Questionnaire for Cognitive Decline
in the Elderly (IQCODE; Jorm, 1994). This instrument assessed the extent to which the
subject’s cognitive abilities had declined over the preceding 4-year and 10-year intervals.
Higher scores on this measure indicate greater impairment. Informants were also asked
the same set of risk factor questions, including a third-person version of the depression
interview.
Participants with a positive cognitive screening, defined as a score less than or
equal to 90 points out of 100 on the 3MS (adjusted for education and sensory
impairments) or an IQCODE composite score greater than or equal to 3.27, were selected
for CA visit. Also selected for CA were members of a designated control panel initially
selected in Wave 1 (Breitner et al., 1999), which was replenished in Wave 3 with
additional random sampling to replace members lost to attrition. This designated control
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panel was randomly stratified for age, gender, and APOE genotype, weighted to yield a
2:1 ratio of controls to persons with a positive cognitive screening, except for the
youngest two strata (65-69 and 70-74 years) with zero or one e4 allele at APOE for
whom a 4:1 ratio was used. In addition, all participants 85 years of age and older were
selected for the CA visit. Thus, a substantial portion of those completing the CA visit
were not selected due to positive screening results. Consequently, the final sample of CA
visit participants is a more heterogeneous mix of subjects who were cognitively normal,
had mild cognitive impairment, or had dementia.
The CA visit included a brief neurological exam, a clinical history from an
informant (typically spouse or adult child of the subject), an informant-based
Neuropsychiatric Inventory, the Patient Health Questionnaire-9 (PHQ-CA), and a battery
of neuropsychological testing, administered by a trained psychometrician. A board
certified geriatric psychiatrist and neuropsychologist reviewed the testing from the CA
visit with the examiners in “case staffing” reviews. After review they assigned
participants to working diagnoses of dementia (according to DSM-III-R criteria),
vascular dementia (according to NINDS-AIREN criteria; Roman et al., 1993), AD,
probable AD, possible AD (according to NINCDS-ADRDA criteria; McKhann et al.,
1984) or other classifications, such as dementia of unknown etiology, demented-not AD,
mild/ambiguous (not meeting criteria for dementia, with suspected prodromal AD), or
other (cognitive symptoms dissimilar from prodromal AD, such as a stroke or
schizophrenia), and noncase.
Only those subjects with a provisional diagnosis of dementia or prodromal
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Alzheimer’s disease were selected for the physician evaluation. Physicians rendered a
new working cognitive diagnosis (blinded to the initial diagnosis rendered at the CA case
staffing meeting). This diagnosis matched the CA case staffing diagnosis for 167 of the
participants (65%). Discrepancies were generally minor for the other participants (e.g.,
“possible AD” versus “probable AD”). A final diagnosis was obtained after all these
procedures by consensus of an expert panel of specialists. One or more board certified
geriatric psychiatrists, neurologists, neuropsychologists, and neuroscientists reviewed all
information and assigned participants a final diagnosis from a list of 30 differential
diagnostic categories.
Use of human subjects and all procedures employed were approved by the
Institutional Review Boards of Duke University Medical Center, the Johns Hopkins
Bloomberg School of Public Health, and Utah State University. Written informed consent
was obtained prior to every interview.
Measurement Scales
Of all the measures collected on study participants at the screening visit, the CA
visit and the MD visit, only those pertaining to assessment of depression are included in
the present work. Each is described in more detail below, including psychometric
properties.
The Diagnostic Interview Schedule –Depression Scale (DIS; Robins et al., 1981)
was completed at the screening visit of each wave, and was used in the present work to
derive a “prior major depression history” subject characteristic variable (coded as
positive/negative report of major depression, up to and including Wave 2). No other
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depression measure was collected at the screening visit, so this visit does not contribute
depression data from multiple sources, the focus of this project.
The DIS assesses a variety of psychological disorders. Both clinicians and lay
interviewers can administer this measure. The DIS yields lifetime and recent diagnoses,
as well as onset of recent diagnoses (occurred in last 2 weeks, last month, last 6 months,
or last year). To ascertain whether lay interviewers could reliability administer the DIS in
the place of clinicians, Robins et al. assessed agreement between lay interviewer and
psychiatrists on lifetime diagnosis (Robins et al., 1981). Overall, Kappa statistics for
showed good agreement (κ = .63). Overall sensitivity and specificity were also good
(80% and 84%, respectively), as was sensitivity for current patients (sensitivity = 79%
and specificity = 81%) and former patients (sensitivity = 82% and specificity = 67%).
The Cache County study modified the DIS by including three “gateway”
questions asking whether the subject had experienced two or more consecutive weeks of
sadness, anhedonia (inability to experience pleasure from life events that are normally
pleasurable), or irritability. If respondents endorsed at least one of these three symptoms
then interviewers asked DIS questions dealing with specific symptoms, including appetite
or weight change, sleep or concentration difficulties, guilt, restlessness, diminished
energy level, or suicidal ideation. Interviewers also asked for year, month, and symptoms
of any depressive episodes that had happened during the preceding wave interval.
Diagnosis of major depression was assigned following Blazer, Hughes, and George
(1987), when subject endorsed five or more DIS symptoms (one of which being sadness
or loss of interest).
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Patient Health Questionnaire (PHQ-9) is the 9-item depression module of the
PHQ, a multi-diagnostic instrument which itself is a brief form of the Primary Care
Evaluation of Mental Disorders (PRIME-MD; Spitzer, Kroenke, & Williams, 1999)
scale. In the CCSMHA, the PHQ-9 was self-administered. Major depressive disorder is
characterized by the instrument as five or more of the nine depressive symptoms for at
least “more than half the days” in the past 2 weeks, with one of the symptoms being
depressed mood or anhedonia. Each of the nine DSM-IV criteria is scored on a “0” (not
at all) to “3” (nearly every day) severity scale, resulting in a total score that can range
from 0 to 27 points. Scores of 5, 10, 15, and 20 on the PHQ-9 indicate mild, moderate,
moderately severe, and severe depression, respectively. Subjects exhibiting any
symptoms answer a question about the functional impact of the disorder.
The PHQ-9 has demonstrated adequate construct validity (Kroenke et al., 2001).
PHQ-9 scores were compared with clinician diagnoses of depression, where the clinicians
utilized the Structured Clinical Interview for DSM-III-R (Spitzer et al., 1992) and
diagnostic questions from the PRIME-MD (Spitzer et al., 1999) in reaching diagnoses.
Kroenke and colleagues found that 93% of participants diagnosed as non-depressed by
the clinician had scores lower than 10 on the PHQ-9, and 88% of participants diagnosed
as having major depression by the clinician had scores of 10 or greater on the PHQ-9.
The PHQ-9 was collected at the CA and the cutoff (> 10) was used in the present study to
indicate major depression. For my analyses, I used only participants that had responded
to most of the items on this measure (at least five out of the nine items). If these subjects
had any missing responses, I added to the total score the mean of the non-missing
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responses for each item that was missing. This method is described in further detail in
Appendix B.
Neuropsychiatric Inventory (NPI; Cummings et al., 1994) uses semi-structured
interviews to measure ten behavioral domains, with depression/dysphoria being the only
domain examined for this thesis. Informants are given a gateway question, in which they
are asked if the subject has seemed sad or depressed in the previous four weeks. If the
answer is affirmative, 15 subquestions are asked. After asking the subquestions, the
interviewer asks questions about the frequency of symptoms, coded as: 1 = occasionally,
less than once per week; 2 = often, about once per week; 3 = frequently, several times per
week but less than every day; 4 = very frequently, once or more per day or continuously.
Severity is coded as: 1 = mild, 2 = moderate, 3 = severe. Frequency and severity scores
are multiplied together to yield the NPI raw depression score that can range from 0-12
(Steinberg et al., 2004). The NPI can be administered by a variety of professionals. The
CCSMHA collected the NPI at the CA via research nurse and at the physician evaluation
by the geropsychiatrist, using identical scoring protocols.
The NPI was found to have good content validity, construct validity, and
reliability (Cummings et al., 1994). A panel of 10 geriatric psychiatry experts rated NPI
items on how well they represented the essential nature of the behavior. Mean rating was
1.2 (1 = good, 4 = poor) for the depression/dysphoria screening question and 1.3 for the
depression/dysphoria subsections. Construct validity was also good; Spearman
correlations comparing frequency, severity, and frequency x severity depression/
dysphoria scores with the “affective disturbances” subscale score of the Behavior
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Pathology in Alzheimer’s Disease Rating Scale (BEHAVE-AD; Reisberg et al., 1987)
were 0.54, 0.47, and 0.33, respectively. Internal consistency was adequate (Cronbach’s
alpha = 0.88). Only 22% of the items were correlated, demonstrating adequate item
independence. Inter-rater reliability was 97.9% for both frequency and severity of
depression/dysphoria. Test-retest reliability was also good; coefficients were 0.79 and
0.84 for frequency and severity, respectively. Following Schneider and colleagues
(2001), I used a cutoff of  4 to indicate major depression. For my analyses, I used only
participants that had a non-missing response to the gateway question. No participants at
the MD visit, and less than 1% of participants at the CA visit were missing responses to
this question.
Geriatric Depression Scale (GDS; Yesavage et al., 1982) is specially designed for
the elderly. For this measure, subjects respond yes or no to each of its 30 items related to
current depressive symptoms. In 20 of the questions a “yes” response indicates
depression, while in the other 10 questions a “no” response indicates depression. One
point is given for each item indicating depression, yielding a possible range of 0-30
points. Because researchers began collecting data on this measure part way through the
Wave 3 MD visit, not all persons that participated in this visit were given this measure.
Yesavage and colleagues (1982) confirmed the validity and reliability of the GDS.
Construct validity was demonstrated in that this measure correlated well with other
depression measures (HAM-D): r = .83, and Zung Self-Rating Depression Scale (SDS): r
= .84], and was further demonstrated in that mean GDS scores were found to be
increasingly greater in participants characterized as normal, mildly depressed, and
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severely depressed according to research diagnostic criteria (RDC; Spitzer, Endicott, &
Robins, 1978). In addition, the authors found the GDS to be reliable. Median correlation
of items on the GDS with its total score (r =.56) was comparable to that of other
depression measures (HAM-D: r =.44, and SDS: r =.56]. Mean correlation among all
GDS items (r =.36) was comparable to mean correlation among all HRS-D items (r =.25)
and among all SDS items (r =.34). Cronbach’s alpha for the GDS was high (r =.94), as
was split-half reliability (r =.94), and test-retest reliability (r =.85).
The present study used a GDS cutoff score of  10 to indicate major depression.
A study by Lyness and Noel (1997) found that this cutoff achieved a sensitivity of 100%
and a specificity of 84% when compared with the Structured Clinical Interview for the
DSM III-R (Spitzer et al., 1992). For my analyses, one participant was missing responses
on 27 of the 30 items, and so was removed. The remaining participants were missing no
more than 3 of the 30 items.
Physician’s Clinical Rating of Depression was also completed during the in-home
physician evaluation. Because researchers began collecting data on this measure part way
through the Wave 3 physician evaluation, not all persons that participated in this visit
were given this measure. This assessment was conducted by geriatric psychiatrists and
internal medicine physicians with a specialty in geriatric psychiatry. Assessment protocol
(see Appendix A) given to physicians stated that they could review the most current NPI
and the GDS from the MD visit, and also that they could gather information from
subjects during the visit. To aid diagnosis, the protocol also included a list of major
depressive symptoms and guidelines on diagnosing minor depressive disorder, bipolar

46
disorder, and mood disorder not otherwise specified (NOS). The protocol instructed
physicians to classify participants into one of five categories: no current depression,
current major depressive episode, current minor depressive episode, mood disorder NOS,
and bipolar disorder. The present study categorized participants as to whether the
physician rated them to have major depression. Acknowledging that this physician
evaluation did not include a full psychiatric evaluation for depression, the diagnoses
rendered represent the physicians’ best “clinical impression” of the subject’s current
depressive state, for the purpose of assigning subjects to “working research diagnoses.”
Summary of depression measures. Table 1 lists the depression measures that
were compared. At the CA, the strength of association was evaluated between the PHQ-9
and the NPI. This comparison had a sample size of 1,481 subjects. At the MD visit, the
following associations were evaluated: the GDS versus the NPI, the GDS versus the
Physician’s Clinical Rating of depression, and the NPI versus the Physician’s Clinical
Rating of depression. There were 136 cases used for these comparisons. To facilitate the
reporting of findings, I will hereafter refer to the PHQ-9 and the NPI from the CA visit as
the “CA-Self” and the “CA-Informant,” respectively, and to the GDS, the NPI from the
MD visit, and the Physician’s Clinical Rating of depression as the “MD-Self,” the “MDInformant,” and the “MD-Doc,” respectively. Table 2 reports the distribution of each
depression measure as a continuous variable.
Subject characteristics. Subject gender was noted at the initial interview and age
was recorded at each interview. To define subject cognitive status, the final expertconsensed diagnosis from the CA was used, coded into the trichotomy of: noncase, mild/
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Table 1
Depression Measures
CA (n = 1,481)
──────────
Report type

Major Dep. Criteria

Instrument

Self-report

CA-Self

≥5

MD-self

Informant report

CA-Informant

≥4

MD-informant

Clinician report
a

Instrument

MD (n = 148)
──────────

N/A

N/A

MD-doc

Major Dep. Criteria
≥ 10

a

≥4
0-1

MD-Doc = Physician’s Clinical Rating

Table 2
Distribution of Depression Measures
Report type

Scale

Min

Max

Mean

SD

CA-Selfa

0-27

0

23

3.3

3.9

CA-Informantb

0-12

0

12

0.4

1.4

MD-Self c

0-30

0

19

6.7

4

MD-Informant

0-12

0

12

1.3

2.6

a

CA-Self =Patient Health Questionaire-9,
CA/MD-Informant= Neuropsychiatric Inventory from
c
CA or MD visit, MD-Self = Geriatric Depression Scale,
b

other cognitive impairment, and dementia, for analyses of CA visit data, but coded into
only the latter two categories for analyses of MD visit data (since noncases did not
complete this visit). Prior depression history was dichotomized into “major depression”
versus “no major depression” spanning the subjects lifetime from birth through the Wave
2 screening visit.
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Data on medical conditions and use of medications with depressogenic side
effects were also available. These medications included interferon, and medications from
the following classifications: beta blockers (e.g., atenalol, propranolol, metoprolol are
some generic names; Physician’s Desk Reference, 2010) and steroids (e.g., prednisone;
(Brown, Vera, Frol, Woolston, & Johnson, 2007). Medication information was recorded
at the CA visit, and was updated by the physician at the MD visit. Information on medical
conditions was collected at each of the screening visits. Because many subjects had at
least one medical condition, subjects were dichotomized into whether they had two or
more of the following conditions at any of the four waves: heart attack, stroke,
hypertension, diabetes, and hypercholesterolemia, or a coronary artery bypass graft.
Informant characteristics. Informant characteristics included relation to subject,
frequency of contact with the subject, age, gender, and how long informants had known
the subject. Relation was defined as spouse versus non-spouse. Frequency of contact was
defined as those who lived with the subject versus those who did not live with the
subject. Age was categorized as less than 65 years old versus 65 years old or older. How
long the informant had known the subject was defined as less than 55 years old versus 55
years old or older. To assess whether the informant relationship with the subject and the
number of years the informant had known the subject were too highly correlated to justify
examination of each as distinct moderators, I computed Pearson correlations between
these factors. This analysis, summarized in detail in Appendix B, found these factors to
be distinct constructs, permitting separate examination of each as a potential moderator of
associations between depression reports.
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Data Analysis
Because elapsed time between visits in the CCSMHA multi-stage dementia
ascertainment protocol varied from 3 to 24 months, analyses conducted for this thesis
project were restricted to those comparing depression measures within visits. This avoids
analyses where data source (self, informant, physician) is confounded with elapsed time.
When comparing depression reports between sources and across time, it would not be
possible to disentangle extent of disagreement attributable to each of these two factors.
Additionally, covarying elapsed time would not be sufficient to “correct for” depression
remission or new-onset depression occurring over the interval.
Research Question 1
To ascertain the prevalence of major depression as reported by subjects,
informants, and physicians, I computed the prevalence of major depression on each
measure, along with the overall prevalence of major depression at each visit, collapsing
over the multiple depression assessments and counting as depressed if any measure was
coded as positive for depression.
To assess basic agreement between these sources, I reported crosstabulations
within each of the source comparisons examined in this study. Also, I calculated the
Kappa statistic, a measure of inter-rater agreement of categorical data, which differs from
traditional inter-rater agreement statistics in that it assesses the proportion of agreement
beyond agreement which can be attributed to chance. It is computed by dividing the
number of cases for which raters agree by the total number of cases, subtracting from this
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the proportion of cases for which agreement between raters could be attributed to chance,
and then dividing this number by proportion of cases for which agreement cannot be
attributed to chance. Because raters are more likely to agree that a condition is not present
if the prevalence of the condition is low, the proportion of cases for which agreement
between raters could be attributed to chance is computed by taking into account the
average prevalence of the condition across raters. A Kappa score of 1 indicates perfect
interrater agreement, a Kappa score of 0 indicates no agreement other than that expected
by chance, and Kappa scores less than 0 indicate less agreement than that expected by
chance. To test the statistical significance of Kappa, a null hypothesis of 0 is used, and p
values are calculated using the normal distribution (Sim & Wright, 2005). Table 3 lists
the strength of agreement for different ranges of Kappa values as suggested by Landis
and Koch (1977).
To further assess the associations between self-report, informant report, and the
physician report I used Logistic Regression (LR), with the rationale that this approach
would also facilitate tests of moderation through inclusion of interaction terms, as needed
Table 3
Strength of Agreement of Values of Kappa
Kappa statistic
<.00

Strength of agreement
Poor

0-0.20

Slight

.21-.40

Fair

.41-.60

Moderate

.61-.80

Substantial

.81-1.00

Almost perfect
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to address Research Questions 2 and 3 (see below). In models including the MD-Doc, I
regressed MD-Doc on MD-Informant and MD-Self, since this measure is hypothesized to
be the “gold standard.”
In logistic regression models comparing subject and informant reports, I regressed
subject rating on informant rating in both instances (i.e., MD-Self was regressed on MDInformant, and CA-Self was regressed on CA-Informant). Comparisons between
informant and subject measures (whether using Kappa or logistic regression) did not
involve a gold standard, and thus did not ascertain which source is more accurate. It
does, however, indicate the extent to which these sources agree.
Significance in logistic regression models was determined by the Wald and -2 log
likelihood change (-2LL change) statistics. The -2LL change statistic represents the
improvement in fit that results from adding a term to the model, which in this case would
be the depression measure entered as the predictor variable. This statistic is computed by
subtracting the -2LL statistic from the model with the term in it (in this case, the model
with the depression variable entered) from the -2LL statistic from the model without the
term in it (in this case, the intercept only model). Since this statistic is distributed as a
chi-square statistic, one can determine the significance of this value using a chi-square
significance table. Typically (though not always) the Wald and -2LL test results are
consistent, but I took the conservative approach in considering the test of association
between the two measures to be significant only if both test statistics were significant at
the p < .05 level.
In addition, to assess the cut points on the MD-Self and MD-Informant that most
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closely predict major versus no major depression on the MD-Doc, receiver operating
characteristic (ROC) analyses were planned but not conducted because of sample size
issues.
Research Question 2
To assess whether the associations between self-reports, informant reports, and
physician’s reports are affected by subject characteristics; original regression models
were expanded to include subject moderators and their interaction with depression
measures. A significant interaction term, which was indicated when the Wald statistic and
the -2LL change statistic (difference between -2LL between model with and model
without interaction) were significant at the p < .05 level, signified that the association is
moderated by the subject characteristic tested in the interaction term. Subject moderators
were tested in all four source comparisons: CA-SELF versus CA-Informant, MD-Self
versus MD-Informant, MD-Doc versus MD-Self, and MD-Doc versus MD-Informant.
Each subject characteristic was analyzed separately for potential moderating
effects. In the MD-Doc versus MD-Self model that tested the dementia moderator, only
the MCI/OCI and demented categories were used because cognitively normal persons did
not go to the MD visit. When a subject characteristic had a significant interaction (i.e.,
was found to be a moderator), I then conducted models that included only the source
comparison, stratified by each level of the subject characteristic. For example, if the
interaction term that included subject gender was significant, I ran the model that
included the source comparison among only males, and then the same model among only
females. These analyses revealed the manner in which the source comparison was
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affected by the subject characteristic. For instance, the stratified models could reveal that
the source comparison was significantly associated within only one level of the
moderator, or they could reveal that the source comparison was more strongly associated
in one level of the moderator than in another, possibly even in opposite directions. Each
of the subject characteristics was tested for potential moderation on the condition that
adequate sample size conditions were met. Two such conditions had to occur. First, that
of the 1,481 subjects that participated at the CA visit at either Wave 3 or Wave 4, and of
the 148 subjects that participated at the MD visit at either Wave 3 or Wave 4, each
subject moderator had to have no more than 20% missing data. Second, each three-way
cross-tabulation between the subject moderator and its respective source comparison had
to contain enough cases in its cells for the model to converge.
Research Question 3
For Research Question 3, to assess whether the association between sources was
affected by informant characteristics, the same approach was used as in Research
Question 2; original regression models were expanded to include informant variables and
their interaction with depression measures. Significant interaction terms indicated that the
association was moderated by the informant characteristic tested in the interaction term,
and for informant characteristics with significant interactions, I conducted separate
models stratified by each level of the informant moderator. Informant moderators were
tested in each of the four source comparisons: CA-SELF versus CA-Informant, MD-Self
versus MD-Informant, MD-Doc versus MD-Self, and MD-Doc versus MD-Informant. As
with Research Question 2, each of the informant characteristics was tested on the
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condition that each informant characteristic had no more than 20% missing data, and that
each three-way cross-tabulation between the informant characteristic and its respective
source comparison had enough cases in its cells for the model to converge.
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CHAPTER IV
RESULTS
This chapter reports results of statistical analyses described in the previous
chapter, to address each of the three research questions in this thesis. Given that there
were two depression measures collected at the CA and three depression measures
collected at the MD visit, there are four within-visit comparisons targeted. These include:
CA-SELF versus CA-Informant, MD-Self versus MD-Informant, MD-Self versus MDDoc, and MD-Informant versus MD-Doc, results of which are reported in this chapter, in
this order, within each research question. Additionally, when reporting results for
Research Questions 2 and 3, not every subject and informant characteristic was able to be
examined for moderator effects, due to data limitations. Nevertheless, within each of
these two sections, I have provided some information—either results of statistical
analysis or explanation as to data limitation(s) that precluded their examination. This
information is provided for each of the subject and informant characteristics targeted in
the prior chapters of this thesis, in the same order, within each research question.
Research Question 1
Research question 1 sought to assess the strength of association between subject
self-report, informant report, and physician reports of depression. Table 4 reports the
prevalence of major depression on each measure for each visit, which ranged from 4.4%
to 23.5%, depending on the measure. This table also indicates that subjects were more
likely to report major depression than physicians, and that subjects were more likely to
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Table 4
Prevalence of Major Depression Per Measure and Per Visit

CA-Selfa
a
b
c
d
e
f

CA-Informantb

CA visit
prevalencee
(n = 1,481)

MDSelfc

MDInformant

8.4%
4.4%
11.4%
23.5%
13.4%
PHQ = Patient Health Questionaire-9.
CA/MD-Informant = Neuropsychiatric Inventory from CA or MD visit.

MD-Docd

MD visit
prevalencef
(n = 148)

7.4%

31.8%

MD-Self = Geriatric Depression Scale.
MD-Doc = Physician’s Clinical Rating.
Proportion of participants who met criteria for major depression on one or more CA depression
measures.
Proportion of participants who met criteria for major depression on one or more MD visit depression
measures.

report major depression than informants. It also indicates that informants are more likely
to report major depression than physicians. Generally, prevalence of depression was
higher at the MD visit than at the CA visit. In addition to reporting the prevalence of
major depression on the MD-DOC, in Table 5 I also reported the frequency of each
diagnostic category from that measure. This table indicates that minor depression and
mood disorder were about as common as major depression, and that bipolar disorder was
not diagnosed at all. Tables 6 through 9 report crosstabulations within each of the source
comparisons examined in this study. In general, these tables indicate higher agreement
between the informant and the physician than between the subject and either the
informant or the physician.
Tables 10 and 11 report results from Kappa statistics that tested the agreement
between source, and from logistic regression models that tested the overall association
between sources. Agreement between subject and informant reports of depression was
poor. Although the Wald statistic and the -2LL change are significant in the model
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Table 5
Number of Persons Diagnosed into Each Category of MD-DOC
Diagnostic category
No current depression
Current major depressive episode
Current minor depressive episode
Mood disorder
Bipolar disorder
Total

Frequency
111
11
11
15
0
148

%
75
7.4
7.4
10.1
0

Table 6
CA-Self by CA-Informant

CA-Self
No major depression
Major depression
Total

CA-Informant
───────────────────────────
no major depression
major depression
────────────
─────────────
n
%
n
%
1,197
43
100
11
1,297
96
54
4

total
1,240
111
1,351

%
91.8
8.2
100

total
77
25
102

%
75.5
24.5
100

Table 7
MD-Informant by MD-Self

MD-Self
No major depression
Major depression
Total

MD-Informant
───────────────────────────
no major depression
major depression
────────────
─────────────
n
%
n
%
68
9
20
5
88
86.3
14
13.7
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Table 8
MD-Doc by MD-Self

MD-Self
No major depression
Major depression
Total

MD-Doc
───────────────────────────
no major depression
major depression
────────────
─────────────
n
%
n
%
99
5
28
4
127
93.4
9
6.6

total
104
32
136

%
76.5
23.5
100

total
93
15
108

%
86.1
13.9
100

Table 9
MD-Doc by MD-Informant

MD-Informant
No major depression
Major depression
Total

MD-Doc
───────────────────────────
no major depression
major depression
────────────
─────────────
n
%
n
%
89
4
10
5
99
91.7
9
8.3

Table 10
Kappa for Source Comparisons
Source comparison
a

Kappa
b

MD-Doc / MD-Self
0.1
c
MD-Doc / MD-Informant
0.35***
CA-Selfd/ CA-Informant
0.08***
MD-Informant / MD-Self
0.01*
a
MD-Doc =Physician’s Clinical Rating.
b
MD-Self = Geriatric Depression Scale.
c
CA/MD-Informant=Neuropsychiatric Inventory.
d
PHQ-=Patient Health Questionaire-9.
*p < .05
*** p < .001
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Table 11
Regression Models for Overall Source Comparisons
Source
d

CA-Self / CA-Informant

e

MD-Informant / MD-Self

f

MD-Doc

a

/ MD-Self

b g

MD-Doc

a

/ MD-Informant

c h

n size

OR

95% CI of OR

Wald

-2LL change

1,351

3.1

1.5

6.1

10.1**

8.2**

102

1.9

0.6

6.3

1.1

1

136

2.8

0.7

11.2

2.2

2.1

108

11.1

2.6

48.3

10.3**

9.9**

a

MD-Doc =Physician’s Clinical Rating.
MD-Self = Geriatric Depression Scale.
c
CA/MD-Informant = Neuropsychiatric Inventory.
d
PHQ = Patient Health Questionaire-9.
e
CA-SELF regressed on CA-Informant.
f
MD-Informant regressed on MD-Self.
g
MD-Doc regressed on MD-Self.
h
MD-Doc regressed on MD-Informant.
*p < .05.
** p <.01.
b

assessing the association between the CA-Self and the CA-Informant (p < .01), the Kappa
statistic was only .08 (p = .001), indicating poor agreement. Table 11 also contains results
from the model comparing the MD-Informant and the MD-Self. For this model, the Wald
statistic, the -2LL change, and the Kappa statistic (κ =.1, p = .30) were not significant.
Subject reports and physician reports of depression were found to be virtually
unrelated. In the model comparing the (MD-Doc) and the MD-Self, neither the Wald
statistic nor the -2LL change are significant, indicating that the MD-Self cannot predict
outcomes on the MD-Doc. The Kappa statistic for these measures (κ =.1, p = .13) was
also not significant.
In contrast, informant reports and physician reports were related, and the
association between these sources was moderate. In the model comparing the MD-Doc
and NPI informant reports from the MD visit, both Wald statistic and -2LL change are
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significant at the p < .01 level, and Kappa indicates fair agreement (κ = .35, p < .001).
Because only nine persons were diagnosed with major depression on the MD-Doc, I was
unable to conduct ROC analyses, which were designed to find the optimal cutoffs on the
MD-Self and MD-Informant for predicting cases and noncases on the MD-Doc.
Research Question 2
Research question 2 seeks to ascertain whether the association between subject
self-report and physician report of major depression, and the association between subject
self-report and informant report of major depression, are moderated by subject
characteristics. Table 12 summarizes demographic characteristics of subjects. This table
indicates that on none of these characteristics are subjects missing more than 20% of the
data. However, in the MD-Doc by MD-Self model that included the subject age
moderator, and in the MD-Doc by MD-Informant models that included the subject age
and prior depression history moderators, crosstabulations indicated sparse data in some
cells that precluded testing this moderator (see Tables B17, B23, and B25, respectively,
in Appendix B).
CA-Self Versus CA-Informant
Table 13 reports interactions from the CA-Self by CA-Informant source
comparison. Nearly all of the Wald and -2LL statistics testing for significant moderation
by subject characteristics were not significant, indicating no moderating effects of the
examined variables. The exception was the cognitive status moderator. The Wald and
-2LL change statistics for the interaction are not significant. However, the Wald statistic
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Table 12
Demographic Summary of Subjects

Variable
Subject gender
Males
Females
Missing
Subject age
< 85 years old
85+ years old
Missing
Cognitive impairment
Normal
MCI/OCI
Dementia
Missing
Prior depression history
No prior depression
Prior depression
Missing
Medical conditions
Had < 2 medical conditions
Had 2+ medical conditions
Missing
Medication use
Not taken meds
Taken meds
Missing
a

CA visit
───────────
n
%

MD visita
───────────
n
%

636
844
1

42.9
57
0.1

61
87
0

41.2
58.8
0

961
517
3

64.9
34.9
0.2

85
63
0

57.4
42.6
0

624
628
228
1

42.1
42.4
15.4
.1

10
95
1

6.8
64.6
.7

1,198
226
57

80.9
15.3
3.8

117
26
5

79.1
17.6
3.4

569
912
0

38.4
61.6
0

52
96
0

35.1
64.9
0

1,134
346
1

76.6
23.4
0.1

113
34
1

76.4
23
.7

Based on the total number of persons that took either the MD-Doc or MD-Self at
the MD visit.

for the normal versus MCI/OCI comparison is significant at the p < .05 level. To further
study this interaction, I stratified the CA-Self versus CA-Informant source comparison by
cognitive status. Table 14 reports results for these models. As can be seen, the Wald
statistic and -2LL are significant for only cognitively normal subjects, that is, only the
cognitively normal subjects had significant association between these two measures. In
addition, in Table 15 I report Kappa statistics for the CA-Self by CA-Informant source

x subject gender (male)

a
a

a

a

versus MCI/OCI)

a

NPI = Neuropsychiatric Inventory.

b

*p < .05.

Reference category.

a

a

versus two or

CA-Informant x medications (meds taken versus not taken)

CA-Informant x med. cond. (less than two med. cond.
more)

CA-Informant x subject cognitive status (normal versus dementia)
CA-Informant x prior dep. history (no prior maj. dep. c versus prior maj.
dep.)

CA-Informant x subject cognitive status (normal

CA-Informant x CA visit subject age (<85 versus 85+ yrs. old)
CA-Informant x subject cognitive status (overall interaction effect)

CA-Informant

b

CA-Self Regressed on CA-Informant: Subject Moderators

Table 13

1,351

0.6

2.2

0.6

1,306
1,351

0.3

0.1

0.2

1.1

OR

1,351

1,351

1,349
1,351

1,351

n size

0.1

0.4

0.1

0.0

0.0

0.0

0.3

3.4

12.4

2.5

1.9

1.0

1.6

4.6

95% CI of OR

0.4

0.9

0.5

1.7

4.0*

2.4
4.0

0.0

Wald

0.4

1.0

0.5

3.3
3.6

0.1

-2LL change
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Table 14
CA-Self Regressed on CA-Informant for Each Level of Cognitive Impairment
Cognitive impairment
Normal
MCI/OCIa
Dementia

n size
592
580
179

OR
10.1
1.2
2.7

95% CI of OR
1.9
52.6
0.4
4.3
0.9
7.8

Wald
7.6**
0.1
3.4

-2LL change
5.1*
0.1
3.1

a

MCI/OCI = mild cognitive impairment/other cognitive impairment.
* p < .05.
** p < .01.

Table 15
Kappas for CA-Informant by CA-Self for
Each Level of Cognitive Status
Cognitive status
Cognitively normal
MCI/OCIa
Demented

Kappa
0.13
0.01
0.14

p value
0.001
0.75
0.06

a

MCI/OCI = mild cognitive impairment/other
cognitive impairment.

comparison for each level of cognitive status. This table indicates, that although
agreement between the CA-Self and CA-Informant was highest among demented persons
(κ = 0.14), only agreement on these measures among cognitively normal persons (κ =
0.13) was significant.
MD-Self Versus MD-Informant, MD-Doc
Versus MD-Self, MD-Doc Versus
MD-Informant
Tables 16-18 report interactions used in the models testing the associations
between the MD-Self and the MD-Informant, the MD-Doc and the MD-Self, and the

a

a

MD-Informant x medications (not taken versus taken meds)
Reference category

a

MD-Informant x med. cond. (less than two med. cond. versus two or more)

a

MD-Informant x prior dep. history (no prior maj. dep. versus prior maj. dep.)

a

MD-Informant x subject dementia (normal versus MCI/OCI versus dementia)

a
a

MD-Self x medications (meds taken versus not taken)
Reference category
b
MD-Self = Geriatric Depression Scale

a

a

MD-Self x medical conditions (less than two med. cond. versus two or more)

a

MD-Self x prior dep. history (no prior maj. dep. vs. prior maj. dep.)

a

MD-Self x cognitive status (MCI/OCI versus demented)

b

MD-Self x gender (male)

Interaction (categories)

MD-Doc Regressed on MD-Self: Subject Moderators

Table 17

a

a

MD-Informant x MD visit subject age (< 85 versus 85+ yrs. old)

MD-Informant x subject gender (male)

Interaction (categories)

MD-Self Regressed on MD-Informant: Subject Moderators

Table 16

136

136

131

126

136

n size

102

102

98

94

102

102

0.6

2.2

0.3

0.5

0.2

OR

n size

0.6

0.3

0.1

0.5

1.3

0.0

0.0

0.0

0.0

0.1

0.0

0.0

0.1

0.0

0.0

0.0

11.8

35.0

6.3

10.6

3.1

11.8

4.0

2.8

6.0

16.7

4.1

0.1

.3

0.7

0.2

1.4

0.1

0.8

1.8

0.4

0.0

0.8

-2LL change

0.1

.3

0.7

0.2

1.4

-2LL change

0.1

0.8

1.7

0.4

0.0

0.8

Wald

Wald

95% CI of exp b

95% CI of OR

0.31

OR

a

a
a

MD-Informant x medications (not taken versus taken meds)
Reference category

a

MD-Informant x med. cond. (less than two med. cond. versus two or more)

a

MD-Informant x subject dementia (normal versus MCI/OCI versus dementia)

MD-Informant x subject gender (male)

Interaction (categories)

MD-Doc Regressed on MD-Informant: Subject Moderators

Table 18

107

108

99

108

n size

4.1

0.2

0.5

0.5

OR

0.1

0.0

0.0

0.0

147.5

4.4

12.1

10.6

95% CI of exp b

0.6

1.1

0.2

0.2

Wald

0.6

1.2

0.2

0.2

-2LL change
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MD-Doc and the MD-Informant. The Wald statistics and -2LL changes for these
interactions are not significant, indicating no moderating effects of examined variables.
Research Question 3
Research question 3 seeks to ascertain whether the association between informant
reports and physician reports of major depression, and the association between informant
reports and subject self-reports of major depression, are moderated by informant
characteristics. Table 19 summarizes demographic characteristics of subjects. This table
indicates that all informant characteristics at the MD visit were missing on more than
20% of the sample (most were missing on more than 75%), thus precluding any tests for
moderation by informant characteristics on any of the three MD visit comparisons. At the
CA visit, informant characteristics were likewise missing on more than 20% of the
sample for all but the following: informant gender, informant relationship and informant
frequency of contact. However, as regards the “sparse cell” problem, the test for
moderating effect of informant gender was not possible due to sparse cells in the 3-way
table (see Table B31 in Appendix B), thus limiting tests for moderation by informant
characteristics to only informant relationship and informant frequency of contact for the
one comparison at the CA visit. Thus, the only informant characteristics that could be
examined were informant relationship and informant frequency of contact at the CA visit.
CA-Self Versus CA-Informant
Table 20 reports results from informant moderators tested in the CA-SELF versus
CA-Informant source comparison. The Wald and -2LL change statistics are not
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Table 19
Demographic Summary of Informants
CA visit
──────────
n
%

MD visita
───────────
n
%

Informant variables
Informant relationship
Spouse
653
44.1
18
12.2
Non-spouse
681
46
16
10.8
Missing
147
9.9
114
77
Informant frequency of contact
Lives w/ subject
717
48.4
9
6.1
Not lives w/ subject
537
36.3
3
2
Missing
227
15.3
136
91.9
Informant age
Less than 65 years old
253
17.1
11
7.4
65+ years old
743
50.2
20
13.5
Missing
485
32.7
117
79.1
Informant gender
Males
400
27
3
2
Females
937
63.3
11
7.4
Missing
144
9.7
134
90.5
Years Informant known subject
Less than 55 years
541
36.5
9
6.1
55+ years
550
37.1
14
9.5
Missing
390
26.3
125
84.5
a
Based on the total number of persons that took either the PCR or GDS at the MD visit

Table 20
CA-Self Regressed on CA-Informant: Informant Moderators
Variable

n size

OR

95% CI of OR

Wald

-2LL change

1,222

1.0

0.2

4.4

0.0

0.0

1,151

1.2

0.3

5.2

0.1

0.1

b

CA-Informant x CA visit informant
relationship (spousea versus non-spouse)
CA-Informant x CA visit inf. freq. of contact
(lives w/ subjecta versus not lives w/)
a
Reference category
b
NPI= Neuropsychiatric Inventory
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significant for any of the moderators. These results indicate that agreement between the
informant and other sources is moderated by none of the informant characteristics tested.
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CHAPTER V
DISCUSSION
This study estimated the extent to which information from physicians’
assessments of geriatric depression could be predicted by subjects’ assessments and
informants’ assessments of geriatric depression, and the extent to which informants’
assessments and subjects’ assessments of geriatric depression could predict each other.
Results indicated that, overall, CCMS agreement was best between informants and
physicians. These sources agreed fairly well, with informants being slightly more likely
to report depression than physicians. Agreement between subjects and both informants
and physicians was poor, with subjects being more likely to report depression than the
other sources.
Poor agreement on some comparisons may have occurred because different
measures were used for different sources. Previous studies provide mixed support for
this. For instance, one previous study (McAvay et al., 2005) that used the same
measure—The Structured Clinical Interview for Axis I DSM-IV Disorders—with
subjects and informants found fair to moderate agreement between subjects and
informants on psychological symptoms of depression (diminished interest or pleasure,
depressed mood, worthlessness, inappropriate guilt), suicidal symptoms of depression
(thoughts of death, suicidal ideation), and somatic symptoms of depression (decreased
appetite or weight loss, increased appetite or weight gain, psychomotor agitation or
psychomotor retardation, insomnia or hypersomnia, fatigue or loss of energy)
(psychological: κ =.41, suicidal: κ =.41, somatic: κ =.31). However, this study also found
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poor agreement on cognitive symptoms (indecisiveness or diminished ability to
concentrate or think; κ =.09). In addition, Ott and Fogel (1992) found that agreement
between sources to be high despite the fact that they used different measures. In this
study, caregivers and clinicians agreed quite well (r = 0.92), and subjects and clinicians
agreed moderately well (r = 0.40), despite the fact that subjects, caregivers, and clinicians
used different measures (the GDS, the HAM-D), and the Cornell Depression Scale for
Depression in Dementia, respectively). However, the latter two of these three measures
are different measures than those used in the present study.
Differences between this and previous studies may also have occurred because
subjects in the Cache County Study on Memory and Health in Aging are different in
some regards than participants in previous studies. For instance, subjects in the CA and
MD samples had a mean age of 83.0 years (SD = 5.3) and 85.1 years (SD = 5.8), while
participants in previous studies had mean ages that ranged from 74 to 78. This could
account for lower agreement found in this study, since younger subjects tend to be less
concerned about stigma related to reporting depression, thus increasing the likelihood that
they will report symptoms. In general, prevalence of depression was higher in this study
than in previous studies that assessed prevalence of depression among the elderly. In this
study, the percentage of persons having major depression ranged from 4.4% on the CAInformant to 23.% on the MD-Self, whereas in previous studies the percentage of persons
having major depression ranged from 0.86% to 9.4% (Beekman et al., 1995; Djernes,
2006; Eaton et al., 2007; Steffens et al., 2000). This higher prevalence may have occurred
because subjects in this study were older than subjects in previous studies. Ethnic
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composition was also different in this study; 99.1% of participants in the CA sample were
White, whereas 83.9% and 88% of participants in McAvay and colleagues’ (2005) study
and Snow and colleagues’ study (2005), respectively, were White. It is unclear what
difference this could have made in agreement. In addition, the religious composition at
the CA sample consisted mostly of LDS persons (91.6%), which may have affected
agreement. Participants in the CA sample were similar to participants in previous studies
in terms of gender composition and education.
This study and previous studies may also have differed because of differences in
samples used. Whereas previous studies used participants from clinical samples or
participants receiving medical home care services, the present study used a population.
This makes participants in the Cache County Study more representative of persons in the
U.S. population in general. Subjects and informants that acquire services from clinics
tend to be different from those in the general population. For instance, Kokmen,
Özsarfati, Beard, O’Brien, and Rocca (1996) found that persons in a clinic-based sample
of elderly persons were more likely to be married, to be white collar workers, and to be
highly educated than persons in a population-based sample of elderly persons. Those with
higher education and occupational status are more likely to have educated beliefs about
mental illness, which makes them more likely to report symptoms of depression. Thus,
the population-based sample of participants in the Cache County Study is generally more
representative of persons in the U.S. population in general, at least insofar as bias due to
self-selection to use medical services is concerned. Agreement on depression assessment
may be higher among individuals in the subpopulation who seek medical attention. This
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may be particularly true when seeking medical care for depressive symptoms, as this
behavior likely stems from higher levels of awareness on the part of subject and
informant regarding depressive symptoms, perhaps also enhanced by discussion between
subject and family members concerning subject’s depression, when seeking medical care.
Another key factor that may play a role in this study having relatively poor
agreement between subjects and informant ratings is that different measures were used
with subjects and informants to assess depression. One way in which depression
measures differed is in the length of time over which symptoms were inquired. For
instance, the CA-Informant inquires about symptoms in the previous month, while the
CA-Self inquires about symptoms over the previous 2 weeks. This may have caused
informants to be more likely to report symptoms than the subject. However, in this study
subjects reported depression on the CA-Self more often than on the CA-Informant,
indicating that subjects reported more depression net of these differences. This suggests
that differences between the CA-Self and CA-Informant are due not only to differences in
the length of time over which symptoms were inquired, but also to differences between
sources.
These measures also differed in that informants are given all of the items on the
CA-Informant only if they respond affirmatively on the gateway question, “In the last
month, did (NAME) seem sad or depressed? Does (NAME) say that (HE/SHE) feels sad
or depressed?” Some older adults manifest depression but without the hallmark symptom
of sadness (Gallo & Rabins, 1999). In such cases, informants may still have endorsed
enough of the individual items to constitute a diagnosis of major depression disorder.
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Thus, it is possible that on this measure depression is less likely to be endorsed than on
other measures, such as the CA-SELF. However, if differences between subject reports of
depression (as measured by the MD-Self and CA-SELF) and CA-Informant or MDInformant informant reports of depression were due primarily to the decreased likelihood
of depression endorsement on the CA-Informant or MD-Informant due to the gateway
question, one would still expect that subjects that were rated as depressed on the CAInformant or MD-Informant would be also rated as depressed on the MD-Self or CASelf. Tables 5 and 6 suggest otherwise. Table 5 indicates that only 11 out of the 54
persons diagnosed as depressed on the CA-Informant were diagnosed as depressed on the
CA-Self, and Table 6 indicates that only 5 out of 14 persons diagnosed as depressed on
the MD-Informant were diagnosed as depressed on the MD-Self, which indicates that
disagreement between subjects and informants is not due exclusively to the decreased
likelihood of depression endorsement on the CA-Informant or MD-Informant due to the
gateway question, but also to differences between sources.
Disagreement between sources may also be due to differences between items on
the depression measures. Table 21 explores this possibility. This table compares
symptoms queried in the MD-Self, CA-Self, and NPI and compares these measures to
DSM-IV criteria for major depression. This table indicates that the MD-Self has more
items on depressed mood than the CA-Informant. However, because the MD-Self as a
whole has twice as many items as the NPI (assuming that participants answer all items),
the number of items addressing depressed mood on the MD-Self is not proportionately
larger than number of items on the NPI. Table 21 also indicates that the MD-Self has
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Table 21
Comparison of Depression Items
DSM-IV criteria for major
depression
Depressed mood

MD-Self
7.

Are you in good spirits most of
the time?

25. Do you frequently feel like
crying?

NPI
3.

Sad or in low spirits

2.

Tearfulness or sobbing

16. Do you often feel downhearted
and blue?
9.

Seemed sad or depressed
(gateway question)

CA-Self

2.

Feeling down,
depressed, or
hopeless

1.

Little interest or
pleasure in doing
things

Do you feel happy most of the
time?

15. Do you think it is wonderful to
be alive now?

Diminished interest or
pleasure

1.

Are you basically satisfied with
your life?

2.

Have you dropped many of your
activities and interests?

12. Do you prefer to stay at home,
rather than going out and doing
new things?
19. Do you find life very exciting?
Weight loss or weight gain

6 & 7. Poor appetite/
overeating

Insomnia or hypersomnia

27. Do you enjoy getting up in the
morning?

Psychomotor agitation or
retardation

11. Do you often get restless and
fidgety?

Fatigue or loss of energy

21. Do you feel full of energy?

Feelings of worthlessness
or excessive or
inappropriate guilt

3.

3 & 4. Trouble falling
asleep or staying
asleep/sleeping too
much
5.

Irritable

Do you feel that your life is
empty?

11. Says life is not
worthwhile

17. Do you feel pretty worthless the
way you are now?

13. Feels worthless
8.

Puts self down, feels like
a failure

9.

Says they’re a bad
person, deserves to be
punished

10 & 11. Moving or
speaking slowly/
fidgety and restless

8.

Feeling bad about
self/that they are a
failure/let family
down

12. Says family would be
better off without
him/her

(table continues)
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DSM-IV criteria for major
depression
Diminished ability to think
or concentrate, or
indecisiveness

MD-Self

NPI

26. Do you have trouble
concentrating?

CA-Self
9.

Trouble
concentrating

14. Do you feel you have more
problems with memory than
most?
6.

Are you bothered by thoughts
you can’t get out of your head?

29. Is it easy for you to make
decisions?
30. Is your mind as clear as it used
to be?
Recurrent thoughts of
death, suicidal ideation,
suicide attempt/plan

14. Wishes for death, talks
about killing self

15. Tried to commit suicide
Distress, problems in
social/ occupational
functioning

20. Is it hard for you to get started
on new projects?
28. Do you prefer to avoid social
gatherings?

Other symptoms
Helplessness/
hopelessness

5.

Are you hopeful about the
future?

10. Discouraged, says they
have no future

10. Do you often feel helpless?
22. Do you feel that your situation
is hopeless?
Worry

8.

Are you afraid that something
bad is going to happen to you?

13. Do you frequently worry about
the future?
18. Do you worry a lot about the
past?
Other

4.

Do you often get bored?

23. Do you think that most people
are better off than you are?
24. Do you frequently get upset
over little things?
1.

Currently being treated
for depression

7.

Mood changes a lot

12. Thinks they are
better off
dead/thoughts about
hurting self
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items that address criteria that the NPI does not address, such as insomnia or
hypersomnia, fatigue or loss of energy, lack of concentration or indecisiveness, and
distress or problems in social or occupational functioning, indicating that the MD-Self
addresses a broader range of criteria than the NPI does. This gave subjects a broader
range of symptoms to endorse, which may have increased the likelihood that subjects
endorsed enough symptoms to render a diagnosis of depression. The MD-Self also
contains items that, if not endorsed, indicate depression. For instance, one of the items
states, “Do you feel happy most of the time?” and another states, “Do you enjoy getting
up in the morning?” If subjects do not endorse items such as these, one point is added to
their score. Because these items are not as directly related to depression, subjects that do
not have depression may be more likely to not endorse them, which would increase their
total score, making it more likely that their total scores exceeds the threshold for major
depression. In addition, the MD-Self contains items that elderly persons would endorse
even if they weren’t depressed, such as “Have you dropped many of your activities and
interests?,” “Do you prefer to stay at home, rather than going out and doing new things?,”
“Do you find live very exciting?,” and “Do you feel full of energy?.” Items such as these
make it more likely that elderly persons who are not depressed exceed the threshold for
major depression.
The effect of differences between the CA-Self and CA-Informant on agreement
between sources is equivocal. Although the CA-Self addresses criteria that the CAInformant does not (diminished interest or pleasure, and insomnia or hypersomia) and
thus addresses a broader array of symptoms, the CA-Informant has proportionately more
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items addressing feelings of worthlessness or excessive or inappropriate guilt, and thus
addresses this criterion in more depth. It is unclear how these differences would cause
disagreement between these sources.
Poor association between depression reports may also have been due to various
statistical issues. For instance, poor association between subject reports of depression and
physician and informant reports of depression, relative to the higher association between
informants and physicians, may have occurred because only eleven subjects were
diagnosed as depressed on the MD-Doc, and of these, only nine were used in analyses.
This reduces statistical power to detect associations. However, informants and physicians
agreed moderately well despite the low number of persons diagnosed as depressed on the
MD-Doc, and subjects and informants on the CA-Self and CA-Informant, respectively,
agreed poorly, despite the large number of persons diagnosed as depressed on these
measures (115 and 63), indicating that the relatively lower association between subject
reports and physician and informant reports of depression, relative to the higher
association between informant reports and physician reports, was only partly due to this
sample size issue. Also, poor association between depression reports may have occurred
because I dichotomized depression reports into major depression versus not major
depression. This decreases power to detect associations because it ignores information
about differences between persons in the same group (MacCallum, Zhang, Preacher, &
Rucker, 2002). For example, an alternative coding of “any depression” versus “no
depression” would have resulted in the former group having higher frequency (and
therefore higher power).
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Similar to this study, previous studies found agreement between sources to be
unaffected by most subject and informant characteristics. For instance, McAvay and
colleagues (2005) found agreement between sources to be unaffected by subject gender,
informant gender, and informant frequency of contact, although they also found that
younger informants reported more psychological and cognitive symptoms than older
informants. Snow and colleagues (2005) found that physical illness, functional status and
caregiver burden did not predict discrepancies between subject and informant reports of
depression, and between subject and clinician reports of depression. Similarly, Ott and
Fogel (1992) found that history of depression, age, sex, and education could not predict
discrepancies between self-reports and clinician reports.
However, also similar to the present study, previous studies found that cognitive
impairment is associated with lower agreement between sources. For instance, McAvay
and colleagues (2005) found that agreement between cognitively impaired subjects and
their informants on the cognitive symptoms of depression (indecisiveness or diminished
ability to concentrate or think) was lower than agreement on these symptoms among
cognitively normal persons and their informants. Snow and colleagues (2005) found that
among persons with a previous diagnosis of dementia, awareness of dementia predicted
discrepancies between subject and informant reports of depression, and between subject
and clinician reports of depression. Ott and Fogel (1992) found that the correlation
between subject and clinician reports of depression was lower among subjects with
cognitive impairment. Teri and Wagner (1991) found that dementia severity did not
affect agreement. However, this may have occurred because all of the persons in their
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sample had AD; although dementia severity can vary among persons with AD, range of
dementia severity varies less widely among these persons than among the entire range of
not demented versus demented persons. Having only persons with AD would restrict
range thereby limiting power to observe effects of dementia severity.
This study has found that other informant and subject characteristics did not affect
agreement between sources. This is surprising given previous findings (summarized in
Chapter II) regarding these characteristics; that older persons are more likely to associate
stigma with depression (Roeloffs et al., 2003), that older males with major depression are
less likely to seek treatment (antidepressants and psychotherapy) than older females with
major depression (Hinton et al., 2006), and so forth. These findings may have differed
from this study because subjects were younger in previous studies. However, some
studies were missing specific age information. For instance, Roeloffs and colleagues
reported only that the age of participants in their sample ranged from 18 to 90 years and
that 55.7% of their sample was older than 41 years old. Hinton and colleagues, who did
report specific age information, subject age was comparable to this study; 41.7% of
participants in Hinton and colleagues’ study were 65-74 years old, and 35.21% of
participants study were 75 and older.
Limitations
Some limitations to the present study can be noted. This study analyzed
agreement between sources using different measures for each source. This to some extent
confounds conclusions regarding the strength of agreement between sources.
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Unfortunately, some analyses in this study were precluded by scarce data on informant
characteristics. Also, because the main focus of the MD visit was to diagnose dementia,
physicians may not have dedicated as much time to diagnosing depression as they would
have if their main focus had been diagnosing depression. Further, this study’s physician
visit comparisons were limited because no cognitively normal subjects were included and
the MD visit. Thus, because study physicians understood that the study protocol only
selected subjects for this visit who were initially diagnosed with dementia or
subsyndromal AD, they may have tended to discount subject’s self-report, placing more
emphasis on informant report than on the cognitively impaired subject’s report.
Strengths
This study had the advantage of utilizing population-level data, which increases
representativeness. Also, this study is unique in that it included a higher proportion of
individuals in the oldest-old group (aged 85 and older), providing insights into depression
assessment in this group not included in many studies. In addition, this study utilized a
cognitive status moderator that consisted of an in-depth dementia ascertainment protocol,
instead of a simple cognitive screening test used in some studies.
Clinical and Scientific Relevance
Findings from this study help clarify uncertainties regarding the diagnosis of
depression in late-life. This information can be valuable to clinicians in their work with
elderly persons, in that it could help them identify conditions under which subjects differ
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the most from informants and physicians (i.e., subjects differ the most when they have
mild cognitive impairment and when they are demented). In addition, this information is
invaluable to epidemiologic researchers who study dementia and depression. Finding
presented in this study elucidate the strengths and shortcoming of various rating sources
of depression, and underscores the importance of carefully selecting depression measures
when diagnosing depression among the elderly. Findings from this study also underscore
the importance of triangulation in assessing depression among this population,
particularly when the subject has notable cognitive impairment.
Future Directions
Because this and previous research indicates that agreement is higher between the
informant and physician, future research should further explore informant moderators
associated with higher agreement with the physician, with the goal of finding strata of
informant characteristics most highly associated with agreement with the physician, to
profile “the ideal informant.” In addition, future research should be focused on becoming
more aware of differences between studies using clinic-based data and those using
population-based data in findings regarding rating sources of late-life depression. Finally,
qualitative studies may be an important way to understand the phenomenology of
depression in late life and what factors influence informants and older adults to feel
comfortable disclosing (and even to be aware of) depression.
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Summary
This study found agreement in late-life depression to be highest among
informants and physicians. Agreement in late-life depression among subjects and both
informants and physicians was found to be poor. This agreement was worse than that
found in previous studies. However, because this study examined age groups older than
those used in previous studies, differences in findings in this study likely reflect unique
phenomena among the oldest old. In addition, because this study utilized populationbased data while previous studies used clinical-based data, differences in this study may
also reflect a more representative view of the U.S. population. Poor agreement on some
comparisons occurred in part because different measures were used for different sources.
However, this study elucidates differences between these measures that may account for
differences in agreement.
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Physician’s Clinical Evaluation of Depression
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Cache County Study on Memory Health and Aging
Physician’s Clinical Impression of Depressive Disorder
Subject ID#: ______________

Date of visit: _______________________

Physician ID#: ____________
Physician is to select one of the following codes that most closely corresponds to his/her
clinical impression of the presence of depressive disorder in the participant at the time of
the MD visit. This impression is not intended to be a clinical diagnosis or an assessment
of whether or not the participant meets explicit DSM algorithmic criteria, and does not
assume a complete psychiatric evaluation has been conducted. Rather, it is the
physician’s overall clinical impression for the purposes of assigning a “working research
diagnosis.” This diagnosis is determined through information gathered from the subject
directly and the collateral informant, including the Geriatric Depression Scale which is
self-administered by the subject (Criteria are listed below only as a guide.)
____ (100) no current depression

____

(400) mood disorder NOS

____

(200) current major depressive episode

____

(500) bipolar disorder

____

(300) current minor depressive episode

Major Depressive Episode
In the same 2 weeks, the patient has had 5 or more of the following symptoms, which are
a definite change from usual functioning. Either depressed mood or decreased interest or
pleasure must be one of the five.
1. Mood. For most of nearly every day, the patient reports depressed mood or
appears depressed to others.
2. Interests. For most of nearly every day, interest or pleasure is markedly
decreased in nearly all activities (noted by the patient or by others).
3. Eating and weight. Although not dieting, there is a marked loss or gain of
weight (such as five percent in one month) or appetite is markedly
decreased or increased nearly every day.
4. Sleep. Nearly every day the patient sleeps excessively or not enough.
5. Motor activity. Nearly every day others can see that the patient’s activity
is agitated or retarded.
6. Fatigue. Nearly every day there is fatigue or loss of energy.
7. Self-worth. Nearly every day the patient feels worthless or inappropriately
guilty. These feelings are not just about being sick; they may be
delusional.
8. Concentration. Noted by the patient or by others, nearly every day the
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patient is indecisive or has trouble thinking or concentrating.
9. Death. The patient has had repeated thoughts about death (other than the
fear of dying), suicide (with or without a plan) or has made a suicide
attempt.





Additional criteria:
These symptoms cause clinically important distress or impair work, social or
personal functioning.
They don’t fulfill criteria for Mixed Episode.
This disorder is not directly caused by a general medical condition or the use of
substances, including prescription medications.
Unless the symptoms are severe (defined as severely impaired functioning, severe
preoccupation with worthlessness, ideas of suicide, delusions or hallucinations or
psychomotor retardation), the episode has not begun within two months of the
loss of a loved one.

Minor Depressive Episode
The symptom features and duration are identical to that of major depressive episode with
the exception that fewer symptoms are needed to meet diagnostic criteria (2 out of 9 with
1 of the 2 being depressed mood or loss of interest or pleasure). Exclusionary criteria
include a past episode of major depression or dysthymia. In addition, the significant
distress or impairment criterion found in major depression has been omitted.
Bipolar Disorder
Bipolar disorder has a clinical course that is characterized by the occurrence of one or
more Manic episodes or Mixed episodes. Often individuals have also had one or more
Major Depressive episodes. Episodes of Substance-induced Mood Disorder or of Mood
Disorder Due to a General Medical Condition do not count toward a diagnosis of Bipolar
I Disorder.
Mood Disorder NOS
This category includes disorders with mood symptoms that do not meet the criteria for
any specific mood disorder and in which it is difficult to choose between Depressive
Disorder NOS and Bipolar Disorder NOS.

97

Appendix B
Supplementary Investigations

98
SUPPLEMENTARY INVESTIGATIONS
This section describes supplementary descriptive statistics and analyses. These
descriptions proceed in the order in which they were originally mentioned in this study.
First, I describe the process by which I selected cases from Waves 3 and 4, and then
report analyses assessing the equivalence on a number of demographic factors of
participants taken from these time points. I then describe the mean imputation procedure I
used for the CA-Self. Next, I describe the process by which I determined
multicollinearity between informant relationship and number of years the informant had
known the subject. Finally, I include tables reporting cell size for models that included
moderator variables.
Selecting Between Waves 3 and Wave 4
To ensure independence of observations, I used subjects’ data from only one
wave. I used Wave 3 data if the subject completed Wave 3. Otherwise, I used Wave 4
data. This protocol was followed separately for CA and MD visit, such that if a subject
had CA in both Waves 3 and 4, but MD visit only in Wave 4, then Wave 3 CA data and
Wave 4 MD visit data were used for that subject. The total number of participants used
for each measure overall and within each wave, are listed in Table B1. The MD-Doc and
MD-Self were added mid-way through Wave 3 fieldwork. Because of this, only 127 of
the 357 persons that participated in Wave 3 were given these measures, and of these, 124
completed the MD-Doc and 112 completed the MD-Self.
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Table B1
Number of Persons from Each Wave
Participant
CA-Informant
PHQ_9
MD-Informant
MD-Self
MD-Doc
subject dementia status
CA visit subject age
MD visit subject age
medications
CA visit informant rel. to subject
CA visit informant freq. of contact
CA visit informant age
CA visit informant gender
CA visit years informant known subject
MD visit informant rel. to subject
MD visit informant frequency of contact
MD visit informant age
MD visit informant gender
MD visit years informant known subj.

Wave 3 used
1,203
1,135
279
112
124
1,228
1,226
357
1,228
1,087
1,039
756
1,090
861
45
41
39
44
35

Wave 4 used
243
238
20
24
24
252
252
25
252
247
215
240
247
230
19
0
19
0
12

Total
1,446
1,373
299
136
148
1,480
1,478
382
1,480
1,334
1,254
996
1,337
1,091
64
41
58
44
47

Equivalence of Waves 3 and 4 on Demographic Factors
To determine equivalence across a range of demographic variables between
subjects whose data were from Wave 3 versus from Wave 4, chi-square tests of
independence were conducted (see Table B2). As can be seen, the CA and MDInformant, MD-Self, MD-Doc, MD visit subject age, CA visit informant relationship to
subject, CA visit informant frequency of contact, CA visit informant gender, CA visit
years the informant had known subject, MD visit informant relationship to subject, MD
visit informant frequency of contact, MD visit informant age, and MD visit years the
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Table B2
Wave 3 and Wave 4 Differences
Category

Chi square

p value

CA-Informant (major dep vs no major dep)

0.2

0.63

PHQ 9-CA (major dep vs no major dep)

5.4

0.02

MD-Informant (major dep vs no major dep)

2.5

0.11

MD-Self (major dep vs no major dep)

0.5

0.47

MD-Doc (major dep vs no major dep)

0.0

0.85

subject dementia (normal, MCI/OCI, dementia)

7.9

0.02

CA visit subject age (<85 versus 85+ yrs. old)

11.3

0.00

MD visit subject age (<85 versus 85+ yrs. old)

0.4

0.54

medications (meds taken versus not taken)

7.8

0.01

CA visit informant rel. to subject (spouse versus non-spouse)

3.3

0.07

CA visit informant freq. Of contact (lives with subj vs not lives with)

0.0

0.89

35.6

<.001

CA visit informant gender

1.6

0.21

CA visit years informant known subj. (<55 versus 55+ yrs.)

5.0

0.03

CA visit informant age (<65 versus 65+ yrs. old)

MD visit informant rel. to subject (spouse versus non-spouse)

0.4

0.51

MD visit informant freq. Of contact (lives with subj vs not lives with)

*

*

MD visit informant age (<65 versus 65+ yrs. old)

0.0

0.94

MD visit informant gender

*

*

MD visit years informant known subj. (<55 versus 55+ yrs.)

0.1

0.78

informant had known subject were nonsignificant, indicating that Wave 3 participants
were the same as Wave 4 participants on these factors.
Conversely, Wave 3 and Wave 4 subjects were found to differ on cognitive statusWave 4 subjects were less likely to be MCI/OCI or demented than Wave 3 subjects. The
may be due to the method by which I decided which wave to use for each subject,
described previously. Subjects for whom I used Wave 4 data were subjects who did not
pass the cognitive screen and were thus less cognitively impaired at Wave 3 than subjects
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for whom I used Wave 3 data. This may explain why they were still less cognitively
impaired at Wave 4 than Wave 3 subjects. It was also found that subjects at the Wave 3
CA visit were more likely to be 85 years of age or older (versus less than 85 years of age)
than subjects at the Wave 4 CA visit. The may also be due to the method of deciding
which wave to use; Wave 4 subjects did not pass the cognitive screen and were thus less
cognitively impaired at Wave 3 than Wave 3 subjects, which implies that they were
younger at Wave 3 than Wave 3 subjects, young enough that they may have still been
younger at Wave 4 than Wave 3 subjects at Wave 3. I also found that Wave 4 CA
informants were more likely to have known the subject for more than 55 years (versus
less than 55 years), which is logical, given an additional 3 years elapsed between waves.
In addition, Wave 4 subjects were more likely to use medication with depressogenic side
effects than Wave 3 subjects. This is surprising, given the previous finding that Wave 4
subjects were younger than Wave 3 subjects. I also found that Wave 4 CA informants
were more likely to be less than 65 years of age than Wave 3 CA informants. This may
be because Wave 4 CA informants were slightly less likely to be spouses than Wave 3
CA informants (this difference approached significance—χ2 = 3.3, p = .07), and CA
spouse informants were more likely to be 65 and older than CA non-spouse informants
(χ2 =510.9, p < .001). I also found that Wave 4 subjects were more likely to be depressed
on the CA-Self than Wave 3 subjects, and that Wave 3 subjects had a longer elapsed time
between CA and MD visit than Wave 4 subjects; mean elapsed time was 8.1 months
(SD = 5.6) for Wave 3 subjects and 6.6 months (SD = 2.9) for Wave 4 subjects (p = .031).
It is unclear why these results would occur.
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Mean Imputation Procedure for PHQ-9
If a subject had any missing responses on the CA-Self, I added to the total score
the mean of the nonmissing responses for each item that was missing, provided that no
more than four items were missing. This method of mean substitution differs from that in
which the mean total score of participants with non-missing total scores is imputed as the
mean total score for participants with missing total scores. The latter method has been
discredited because it biases scores towards the average (Graham, 2009). In this study,
the mean of each participant’s non-missing items is imputed as the value for their missing
items, resulting in a more personally tailored estimate of each participant’s total score. Of
the 1,481 persons that went to the CA visit, 107 did not complete the CA-Self or were
missing more than four items, 1,362 completed the entire CA-Self, and 11 completed the
CA-Self but had four or fewer items missing. Of this latter group, an average of 0.79
points (range: 0.25 to 1.60) was imputed to each score. This imputation resulted in two
cases moving from not having major depression to having major depression.
Analyses were conducted to assess the equivalence on a number of demographic
characteristics, as well as on cognitive status, across those who did not complete the CASelf (or were missing more than four items), those who completed the entire CA-Self,
and those who completed the CA-Self but had four or fewer items missing, i.e., those that
received the mean imputation. I used ANOVA to assess equivalence across these
missingness groups on years of education and subject age at the CA visit. Omnibus
ANOVA was significant for years of education, F(2,1469) = 3.9, p = .02. Post hoc Tukey
tests revealed that those who did not complete the CA-Self had significantly fewer years
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of education (M = 12.9) than those who completed the entire CA-Self (M = 13.7). The
mean of the mean imputation group (M = 13.5) was similar to the completed group, but
was not significantly different from the non-completed group, most likely because of low
cell size. Omnibus ANOVA was also significant for subject age, F(2, 1477) = 22.00,
p < .001. Similar to years of education, post hoc Tukey tests revealed that the
noncompleted group was significantly older (M = 86.2) than the completed group (M =
82.7), with the mean imputation group being equivalent to the completed group (M =
82.7). These analyses indicate that participants who received the mean imputation were
similar to those who completed the entire CA-Self in terms of age and education, and that
these two groups were different from those that did not complete the CA-Self in terms of
these factors.
Table B3 presents results from chi-square analyses that assess equivalence across
missingness groups on the remaining demographic factors and on cognitive status.
Ethnicity, marital status, and gender were not significant, indicating that participants in
the different missingness groups were similar on these factors. The chi square test for
cognitive status was significant, χ2 (4, n = 1,480) = 60.8, p < .001. Crosstabulations
Table B3
Equivalence Across Missingness Categories on PHQ-9
Category

Chi square

Ethnicity

11.4

0.08

Marital status

12.2

0.14

3.6

0.17

Gender
Cognitive status

60.8

p value

< .0005
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indicated that those who did not complete the CA-Self (n = 107) were more likely to be
demented than those who did complete the CA-Self (n = 1,362) and those who received
the mean imputation (n = 11). This increased likelihood of dementia may explain why
these subjects could not complete all or some items on this measure, despite being similar
to subjects who completed the measure in terms of age and education.
Determining Multicollinearity Between Informant Relationship and
Number of Years the Informant Had Known the Subject
To assess the possibility that the informant relationship with the subject and the
number of years the informant had known the subject were the same construct, I
computed Pearson correlations between these factors. Because spouses were coded as “1”
and nonspouses were coded as “2,” a negative relationship would indicate that spouse
informants were more likely to have known the subject for longer. This correlations was
low (CA visit: r = -.221, MD visit: r = -.394), indicating that, although the constructs are
similar and overlap, they are dissimilar enough to consider them separately as potential
moderator variables influencing agreement on pairs of depression measures.

Tables Reporting Cell Sizes for Models that Included Moderators
Tables B4-B32 report cell sizes for models that included moderators.
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Table B4
CA-Self by CA-Informant and Subject Gender

CA-Informant
No major depression
Male
Female
Major depression
Male
Female
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

524
673

93.4
91.4

37
63

6.6
8.6

561
736

24
19
1,240

82.8
76.0

5
6
111

17.2
24.0

29
25
1,351

Table B5
CA-Self by CA-Informant and Subject Age

CA-Informant
No major depression
< 85
85+
Major depression
< 85
85+
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

797
398

92.7
91.5

63
37

7.3
8.5

860
435

29
14
1,238

74.4
93.3

10
1
101

25.6
6.7

39
15
1,339
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Table B6
CA-Self by CA-Informant and Dementia

CA-Informant
No major depression
Normal
MCI/OCI
Dementia
Major depression
Normal
MCI/OCI
Dementia
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

567
492
138

97.3
88.0
89.0

16
67
17

2.7
12.0
11.0

583
559
155

7
18
18
1,240

77.8
85.7
75.0

2
3
6
111

22.2
14.3
25.0
1

9
21
24
1,351

Table B7
CA-Self by CA-Informant and Subject Prior History of Depression

CA-Informant
No major depression
No prior major depression
Prior major depression
Major depression
No prior major depression
Prior major depression
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

1,012
148

94.8
79.1

55
39

5.2
20.9

1,067
187

29
12
1,201

85.3
66.7

5
6
103

14.7
33.3

34
18
1,304
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Table B8
CA-Self by CA-Informant and Subject Medical Conditions
CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

CA-Informant
No major depression
Had < 2 medical conditions
Had 2+ medical conditions
Major depression
Had < 2 medical conditions
Had 2+ medical conditions
Total

466
731

94.9
90.7

25
75

5.1
9.3

491
806

21
22
1,240

91.3
71.0

2
9
111

8.7
29.0

23
31
1,351

Table B9
CA-Self by CA-Informant and Subject Medication Use

CA-Informant
No major depression
Not taken meds
Taken meds
Major depression
Not taken meds.
Taken meds.
Total

total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

932
265

92.9
90.1

71
29

7.1
9.9

1,003
294

34
9
1,240

79.1
81.8

9
2
111

20.9
18.2

43
11
1,351
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Table B10
MD-Self by MD-Informant and Subject Gender

MD-Informant
No major depression
Male
Female
Major depression
Male
Female
Total

MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

35
33

92.1
66.0

3
17

7.9
34.0

38
50

5
4
77

71.4
57.1

2
3
25

28.6
42.9

7
7
102

Table B11
MD-Self by MD-Informant and Subject Age

MD-Informant
No major depression
< 85
85+
Major depression
< 85
85+
Total

MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

41
27

82.0
71.1

9
11

18.0
28.9

50
38

7
2
77

70.0
50.0

3
2
25

30.0
50.0

10
4
102
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Table B12
MD-Self by MD-Informant and Cognitive Status

MD-Informant

MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

No major depression
MCI/OCI
Dementia
Major depression
MCI/OCI
Dementia
Total

total

44
18

75.9
78.3

14
5

24.1
21.7

58
23

3
5
70

50.0
71.4

3
2
24

50.0
28.6

6
7
94

Table B13
MD-Self by MD-Informant and Prior History of Depression

MD-Informant
No major depression
No prior major depression
Prior major depression
Major depression
No prior major depression
Prior major depression
Total

MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

62
5

82.7
50.0

13
5

17.3
50.0

75
10

6
3
76

66.7
75.0

3
1
22

33.3
25.0

9
4
98
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Table B14
MD-Self by MD-Informant and Medical Conditions
MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

MD-Informant
No major depression
Had < 2 medical conditions
Had 2+ medical conditions
Major depression
Had < 2 medical conditions
Had 2+ medical conditions
Total

24
44

77.4
77.2

7
13

22.6
22.8

31
57

3
6
77

50.0
75.0

3
2
25

50.0
25.0

6
8
102

Table B15
MD-Self by MD-Informant and Medications

MD-Informant
No major depression
Not taken meds.
Taken meds.
Major depression
Not taken meds.
Taken meds.
Total

total

MD-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

55
13

78.6
72.2

15
5

21.4
27.8

70
18

7
2
77

63.6
66.7

4
1
25

36.4
33.3

11
3
102
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Table B16
MD-Doc by MD-Self and Gender

MD-Self
No major depression
Male
Female
Major depression
Male
Female
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

44
55

95.7
94.8

2
3

4.3
5.2

46
58

5
23
127

71.4
92.0

2
2
9

28.6
8.0

7
25
136

Table B17
MD-Doc by MD-Self and Subject Age

MD-Self
No major depression
< 85
85+
Major depression
< 85
85+
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

58
41

92.1
100.0

5
0

7.9
0.0

63
41

11
17
127

78.6
94.4

3
1
9

21.4
5.6

14
18
136
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Table B18
MD-Doc by MD-Self and Dementia Status

MD-Self
No major depression
MCI/OCI
Dementia
Major depression
MCI/OCI
Dementia
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

63
27

95.5
93.1

3
2

4.5
6.9

66
29

19
8
127

86.4
88.9

3
1
9

13.6
11.1

22
9
136

Table B19
MD-Doc by MD-Self and Prior History of Depression

MD-Self
No major depression
No prior major depression
Prior major depression
Major depression
No prior major depression
Prior major depression
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

86
11

96.6
84.6

3
2

3.4
15.4

89
13

19
7
123

90.5
87.5

2
1
8

9.5
12.5

21
8
131
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Table B20
MD-Doc by MD-Self and Medical Conditions
MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

MD-Doc
No major depression
Had < 2 medical conditions
Had 2+ medical conditions
Major depression
Had < 2 medical conditions
Had 2+ medical conditions
Total

34
65

91.9
97.0

3
2

8.1
3.0

37
67

7
16
127

85.7
88.9

2
2
9

14.3
11.1

14
18
136

Table B21
MD-Doc by MD-Self and Medications

MD-Self
No major depression
Not taken meds.
Taken meds.
Major depression
Not taken meds.
Taken meds.
Total

total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

76
23

96.2
92.0

3
2

3.8
8.0

79
25

22
6
127

88.0
85.7

3
1
9

12.0
14.3

25
7
136
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Table B22
MD-Doc by MD-Informant and Gender

MD-Informant
No major depression
Male
Female
Major depression
Male
Female
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

44
49

95.2
96.1

2
2

4.8
3.9

42
51

4
6
99

57.1
75.0

3
2
9

42.9
25.0

7
8
108

Table B23
MD-Doc by MD-Informant and Subject Age

MD-Informant
No major depression
< 85
85+
Major depression
< 85
85+
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

49
40

92.5
100.0

4
0

7.5
0.0

53
40

6
4
99

60.0
80.0

4
1
9

40.0
20.0

10
5
108
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Table B24
MD-Doc by MD-Informant and Cognitive Status

MD-Informant

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

No major depression
MCI/OCI
Dementia
Major depression
MCI/OCI
Dementia
Total

%

59
23

95.2
95.8

3
1

4.8
4.2

62
24

3
5
90

50.0
71.4

3
2
9

50.0
28.6

6
7
99

Table B25
MD-Doc by MD-Informant and Prior History of Depression

MD-Informant
No major depression
No prior major depression
Prior major depression
Major depression
No prior major depression
Prior major depression
Total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

76
10

95.0
100.0

4
0

5.0
0.0

80
10

8
2
96

88.9
40.0

1
3
8

11.1
60.0

9
5
104
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Table B26
MD-Doc by MD-Informant and Medical Conditions
MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

MD-Informant
No major depression
Had < 2 medical conditions
Had 2+ medical conditions
Major depression
Had < 2 medical conditions
Had 2+ medical conditions
Total

31
58

96.9
95.1

1
3

3.1
4.9

32
61

3
7
99

50.0
77.8

3
2
9

50.0
22.2

6
9
108

Table B27
MD-Doc by MD-Informant and Medications

MD-Informant
No major depression
Not taken meds.
Taken meds.
Major depression
Not taken meds.
Taken meds.
Total

total

MD-Doc
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

71
18

95.9
94.7

3
1

4.1
5.3

74
19

8
1
98

72.7
33.3

3
2
9

27.3
66.6

11
3
108
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Table B28
CA-Self by CA-Informant and Informant Relationship

CA-Informant
No major depression
Spouse
Non-spouse
Major depression
Spouse
Non-spouse
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

555
523

93.9
90.2

36
57

6.1
9.8

591
580

15
25
1,118

83.3
75.8

3
8
104

16.7
24.2

18
33
1,222

Table B29
CA-Self by CA-Informant and Informant Frequency of Contact

CA-Informant
No major depression
Lives with subject
Not lives subject
Major depression
Lives with subject
Not lives subject
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
n
%

total

601
416

92.7
90.8

47
42

7.3
9.2

648
458

16
18
1,051

80.0
72.0

4
7
100

20.0
28.0

20
25
1,151
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Table B30
CA-Self by CA-Informant and Informant Age

CA-Informant
No major depression
< 65 years old
65+ years old
Major depression
< 65 years old
65+ years old
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

197
626

89.1
93.0

24
47

10.9
7.0

221
673

11
16
850

73.3
88.9

4
2
77

26.7
11.1

15
18
927

Table B31
CA-Self by CA-Informant and Informant Gender

CA-Informant
No major depression
Male
Female
Major depression
Male
Female
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

329
752

91.1
92.5

32
61

8.9
7.5

361
813

3
37
1,121

100.0
77.1

0
11
104

0.0
22.9

3
48
1,225
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Table B32
CA-Self by CA-Informant and Number of Years the Informant Had Known Subject

CA-Informant
No major depression
< 55 years old
55+ years old
Major depression
< 55 years old
55+ years old
Total

CA-Self
───────────────────────────
No major depression
Major depression
─────────────
────────────
n
%
MD-Self
n

%

427
454

91.0
91.5

42
42

9.0
8.5

469
496

24
6
911

75.0
85.7

8
1
93

25.0
14.3

32
7
1,004

